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ABSTRACT 
 
ERNESTO PEREZ-CHANONA: Microbial signaling in intestinal  
ischemia/reperfusion injury response 
(Under the direction of Christian Jobin)  
 
The intestine is home to one of the most diverse and populous ecosystems 
on earth. The intestinal epithelium the single layer sheet of columnar cells that 
provides key functions to maintain homeostasis including nutrient absorption and 
metabolism, innate immune system toning and the sampling of luminal contents. 
One of the most important roles of the epithelium is to provide a physical barrier 
between the host and gut microbes. Intestinal epithelial cells (IECs) are stitched 
together by tight junctions that maintain the architecture of the epithelial sheet and 
prevent uncontrolled access of luminal content to the underlying immune system 
compartments and the blood stream. Intestinal ischemia/reperfusion (I/R) 
compromises the integrity of this structure potentially leading to sepsis and multi-
organ dysfunction.  
The epithelium experiences steady-state regeneration through migration and 
proliferation of IECs from the base of the intestinal crypts to tips of the villi. Microbial 
signals through pattern-recognition receptors foster this enterprise. Herein, I discuss 
my insights into the contributions of microbial signals to the host response to 
intestinal I/R-induced injury. I demonstrate the deleterious role of TLR adapter, 
MyD88, and protective role of the intracellular microbial receptor, NOD2. Then, I 
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discuss plausible mechanisms by which these two signaling proteins yield such 
contrasting effects on injury.     
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CHAPTER 1 : INTRODUCTION 
 
 Our interspecies self  1.1.
The study of microbes was born in late 1676, when Dutch microscopist Anton 
van Leeuwenhoek fell ill with the Early Modernist equivalent of the ‘stomache flu.’ 
Curious to determine the cause of his illness, van Leewenhoek took a stool sample 
and observed Giardia lamblia under his home-made microscope1. His initial reaction 
is one that is echoed in modern-day laboratories: Are these bugs causing disease, 
and if so, how? Over the following two centuries, with improvements in microscopy 
in conjunction with accrued evidence that bacteria were causing numerous 
pathologies, the fear of microbes began to spread. However, towards the end of the 
19th century, researchers observed that bacterial infections and the administration of 
microbial peptides had anti-tumor effects in patients, suggesting bacteria-mediated 
immune activation could be harnessed for therapeutic purposes2,3. Indeed, the vast 
majority of microorganisms inhabiting humans and their immediate environment are 
not pathogenic entities, but rather symbionts and commensals implicated in 
essential functions of host homeostasis.
The gastrointestinal tract is the most densely populated organ of the human 
body, with a microbial load ranging from 10 cells per gram of content in the stomach
to 1012 cells per gram in the colon4. These microbial communities, termed the 
microbiota, are predominantly acquired at birth and progressively mature into a 
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stable and adult-like ecosystem by the age of 2-34. 
Until recently, little was known about the identity of these microbes, their 
individual or collective contribution to homeostasis, and their responsiveness to 
environmental cues. To study the relationship between gut microbes and disease, 
advanced high-throughput sequencing of the microbial hypervariable 16S ribosomal 
RNA gene and computational biology has permitted the partial characterization of 
the microbial communities living in the intestine. The abundance and diversity of 
these sequences generate a microbial profile termed the microbiome—the genetic 
contribution of the microbiota—which amounts to 100-fold more genes than those in 
the human genome5. At the phylum level, the gut microbiota mainly comprises 
Firmicutes and Bacteriodetes, forming close to 90% of the total ecosystem, followed 
by lesser contributions from members of Proteobacteria, Verrumicrobioa, 
Actinobacteria, Fusobacteria and Cyanobacteria phyla6,7(Figure 1). This imposing 
microbial mass (~6 pounds of body weight) contains an estimated ~3 X 106 genes, 
providing important metabolic capacity required for both the host and microbial 
fitness4. As a result, Bacteriodes, Bifidobacterium, Clostridium clusters XIVa and 
IVa, Eubacterium, Faecalibacterium, Lactobacillus and Roseburia are microbial taxa 
that have been found to be associated with human health8.  
The function of the gut microbiota has intrigued scientists since the late 19th 
Century, when Pasteur and his colleagues pioneered gnotobiotic technology. By the 
1940s, the Ervin group was breeding successive generations of germ-free mice and 
rats at the University of Notre Dame9. Here, germ-free mice were generated by 
hand-feeding sterile diets to Caesarian born litters. Then, placing the mice in sterile 
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glass jars that hold 5 adults with their litter in a system referred to as the Reyniers 
Germfree Unit. Current methods to generate germ-free animals require the transfer 
of pups from a pregnant, conventional mother to a germ-free surrogate mother. A 
hysterectomy is performed in a ‘transfer chamber,’ where the uterus is placed in a 
sterilizing solution before pups are born10. Alternatively, embryos can be transferred 
into pseudopregnant, germ-free mothers11. The mice are raised in sterile isolators, 
where they are fed sterile food and water. To verify the sterility of the mice, stool 
samples are plated on brain heart infusion (BHI) agar; a robust, non-selective 
medium suitable for the cultivation of fastidious aerobic and anaerobic bacteria, 
yeasts and fungus. A qPCR analysis of the microbial ribosomal 16S rRNA gene is 
also performed on stool samples as a secondary measure of sterility. However, 
these mice are not devoid of microbial products which may be found in the food and 
water, or viruses and parasites, which may have been contracted from the mother. 
To minimize contamination, the isolators are usually administered by a research 
core, which specializes in this type of sterile technique (Bower, Maureen. Interview. 
March 2011).  
  The availability of germ-free animals paved the way for the initial 
characterization of the role of bacteria in general physiological processes.  For 
example, the regional blood flow of organs normally colonized by bacteria, such as 
the skin, lungs and gut, was found to be reduced in germ-free animals by as much 
as 45% compared to the conventional controls12. Also, germ-free rodents were found 
to have a lower mitotic index  (rate of cellular division) and a smaller surface area in 
the small bowel than the controls12. In fact, microbial signals increase the 
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phosphorylation of the epidermal growth factor receptor, and the cell proliferation of 
human colorectal adenocarcinoma SW480 cells13.  Another early study using 
periodic acid-Schiff staining of the small bowel and colon demonstrated that these 
animals contain defects in mucin production and composition12. The same study 
demonstrated that villus length, small bowel crypt depth and colon crypt depth is 
significantly shorter in germ-free animals than in conventionally-raised mice.  
However, the administration of LPS and peptidoglycan directly on to the colonic 
mucosa through intravital microscopy was shown to increase the mucous levels to 
those observed in conventional mice14.   
 Over the past two decades, several key findings demonstrated the 
importance of microbes in immune system development and maturation. While 
secondary lymphoid structures begin developing in the fetal murine gut, postnatal 
colonization by commensal microbes was shown to be necessary for the growth of 
these structures, including cryptopatches and lymphoid follicles15. Cryptopatches are 
clusters of lymphoid tissue inducer-like cells that recruit B-cells to form lymphoid 
follicles similar to Peyer’s patches in the lamina propria4. These structures lack a 
germinal center and contain a disproportionate number of B220+ lymphocytes in 
germ-free mice16.  The differentiation of other immune cell types, such as 
RORγhiNKp46+NK1.1int natural killer-like cells, which recognize and lyse bacterially-
infected host cells, also require commensal microbes17. Remarkably, specific 
members of the gut microbiota have been shown to drive immune cell responses.  
The current challenge in this area of research is how to move from studies 
that correlate the microbiome with a disease state to identifying the mechanisms by 
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which the microbiota impact the host. Early studies addressing the function of the 
microbiota relied on culture-based methods to identify microbes19. For instance, 
Round et al. demonstrated that Bacteroides fragilis, through the action of its cell wall 
component polysaccharide A, fosters the differentiation of Foxp3+ T regulatory cells 
(Tregs); a subset of lymphocytes exhibiting anti-inflammatory properties18. Recent 
efforts by various groups using culture-independent, DNA sequencing-based 
methods to identify microbes have also generated new insight into the functional 
consequences of host-microbe interaction. For instance, Bacteroides 
thetaiotaomicron was identified to cause severe colitis in Il10r2+/- pre-treated with 
antibiotics; a murine model of IBD20. Interestingly, an Enterobacteriaceae species 
was unable to induce disease in these mice. In related study, segmented 
filamentous bacteria (SFB) was discovered to be sufficient to induce T helper 17 
(Th17) cells in germfree Swiss-Webster mice21,22. In contrast to B. thetaiotaomicron, 
the abundance of SFB determined its immunomodulatory capacity.  Although these 
studies demonstrate the importance of microbes in immune system maturation, the 
instances of a single species having a profound effect are low. Indeed, investigation 
into microbial networks is an active area of research that will likely demonstrate how 
groups of microbes function to impact host physiology and disease. 
One of the most important functions of the gut microbiota is their metabolic 
capacity.  Although the richness and diversity of the microbiota differs from one 
healthy individual to the next, it is remarkable that the metabolic capacity between 
the microbial communities remains the same7,23. Core metabolic functions of the 
microbiota include carbohydrate metabolism, vitamin biosynthesis and methionine 
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degradation7,8,24. Ten percent of the host’s energy requirement is fulfilled by the 
microbiota through the production of short-chain fatty acids (SCFAs), namely 
acetate, propionate and butyrate, which result from dietary carbohydrate 
fermentation (Figure 1). In addition to serving as an energy source, these 
metabolites have various important functions in the host. For instance, 
conventionally-raised mice lacking SCFA receptors and wildtype germ-free mice 
showed defective regulatory T-cell populations, suggesting that microbial-derived 
metabolites immunologically educate mucosal immune cells25,26. The 
interdependence between the host, microbes, and their metabolic products clearly 
illustrates the complex symbiosis that has formed over millions years of evolution. 
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Figure 1. The structure and function of the gut microbiota.  
The Human Microbiome Project revealed that members of the gut microbiota differ 
remarkably from one individual to the next due to factors such as the immune 
system development and the environment. Nevertheless, metagenomic data 
demonstrated that the metabolic pathways, including vitamin biosynthesis and SCFA 
metabolism, are consistent among individuals. Other functions of the gut 
microbiota include immune system maturation, barrier function, pathogen exclusion 
and epithelial turnover. Together, these functions demonstrate the importance of the 
symbiotic relationship we share with our gut inhabitants. Adapted from Human 
Microbiome Project Consortium. Structure, function and diversity of the healthy 
human microbiome. Nature 486, 207–214 (2012)7.
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 The intestinal epithelium  1.2.
The epithelium that lines the intestinal tract is composed of a single layer of 
cells forming a sheet that provides nutrient absorption, hormone secretion, and 
sampling of luminal contents6,27. In addition, the epithelium provides a physical 
barrier between the host and gut microbes where intestinal epithelial cells (IECs) are 
stitched together by tight junctions to maintain the architecture of the epithelial 
sheet28. The barrier function of the epithelium is preserved by the homeostatic 
migration and proliferation of IECs from the base of the intestinal crypts to tips of the 
villi, ensuring that the entire epithelial sheet of the human digestive tract is shed and 
replaced in approximately one week. Here, a vast network of arteries branching from 
the superior mesenteric artery satisfies the metabolic demand for this enterprise.  
The microbiota and their metabolic products regulate the health and homeostasis of 
the intestinal epithelium. In order to maintain the integrity of the intestinal epithelium, 
cell proliferation programs are triggered by pattern-recognition receptors (PRRs) 
(Figure 2). Microbes residing in the lumen of the intestine are sampled by these 
innate immune system receptors. Two widely studied families of PRRs are Toll-like 
receptors, TLRs, and Nod-like receptors, NLRs, which recognize microbial-
associated molecular patterns (MAMPs). TLRs are expressed on the apical, 
basolateral, and vesicular membranes of IECs.  For instance, TLR4 recognizes 
lipopolysaccharide (LPS) and maintains a basal level of immune activation. This 
recognition induces the expression and secretion of peptides such as ribonucleases, 
C-type lectins, and S100 proteins which kill microbes, thereby protecting the stem 
cell niche in the crypts of Lieberkühn29.  
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Figure 2. Toll-like receptors (TLRs) and NOD-like receptors (NLRs) (e.g. NOD2) 
are pattern-recognition receptors (PRRs).   
 
In intestinal epithelial cells, intracellular receptor NOD2—a member of the NLR 
family of PRRs—recognizes the derivative of peptidoglycan, muramyl dipeptide 
(MDP). Signaling downstream of NOD2 induces the expression of cytokines, 
chemokines and antimicrobial peptides. Similarly, TLRs recognize microbial ligands 
such as lipopolysaccharide, peptidoglycan, flagellin and bacterial DNA. Most TLRs 
signal through the adapter MyD88 to induce the cytokine and chemokine expression, 
chemokines, cell survival, and development programs.
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 The innate immune receptor NOD2 1.3.
Similar to TLRs, the NLR family of proteins mediate the response to microbial 
entities in the gut. Two widely-studied members are nucleotide-binding 
oligomerization domain-containing protein 1 and 2 (NOD1/2). These proteins 
recognize derivatives of peptidoglycan, a component of the bacterial cell wall. 
NOD2, in particular, has been identified as a genetic risk factor for inflammatory 
bowel diseases (IBD), in particular, Crohn’s disease (CD)30. In CD, loss-of-function 
mutations impairing peptidoglycan sensing have been implicated in disease 
progression. Conversely, NOD2 gain-of-function mutations have been associated 
with auto-inflammatory diseases such as Blau Syndrome and early-onset 
sarcoidosis. Therefore, understanding the biology of NOD2 has been a subject of 
intense research by many groups31-33.  
NOD2 contains two caspase-recruitment domains (CARDs), a nucleotide 
binding domain (NBD) and a series of leucine-rich repeats at the carboxy-terminus 
for ligand sensing (Figure 3). The ligand for NOD2 is muramyl dipeptide, MDP, a 
MAMP present in the cell walls of gram-positive and gram-negative bacteria that is 
transported into the cell by the di-/tripeptide transporter, hPepT1184. The NBDs 
mediate the auto-oligomerization, as well as bind ATP necessary for NOD2 
activation32,34-36. Upon oligomerization, the active NOD2 protein activates the crucial 
adaptor, RIP2, which then recruits TAK1 and activates the IκB kinase complex. This 
signaling pathway results in the downstream activation of transcription factor NF-κB 
and induces an inflammatory response, resulting in the expression and secretion of 
pro-inflammatory cytokines37. In IECs, expression of NOD2 is up-regulated by TNF 
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and IFNγ signaling, as well as by a positive feedback loop where NF-κB is recruited 
to the Nod2/Card15 promoter38. NOD2 also promotes the activation of the MAP 
kinase pathways through ERK, ERK2, JNK and p3838 and the PI3K pathway through 
phosphorylated AKT39. 
Although the basal levels of NOD2 are quite low in the intestinal epithelium, 
microbial signals such as LPS (Perez-Chanona & Jobin, personal observation) and 
butyrate increase NOD2 expression32,40. Recently, Nigro et al. have shown that 
Lgr5+ stem cells express five times the level of Nod2 message compared to Paneth 
cells, fostering epithelial recovery after doxorubicin-induced DNA damage. The 
mechanism by which this occurs has not been elucidated41. In macrophages, Hsu 
and colleagues demonstrated that NOD2 interacts with caspase-1 to trigger the 
NLRP1 inflammasome and the release of IL-1β42. Together, these findings indicate 
that although NOD2 expression is regulated differently between cell types, it likely 
mediates cytoprotective functions in the intestinal epithelium.  
 The canonical function of NOD2 is to serve as a part of the luminal 
surveillance mechanism designed to maintain microbe populations at homeostatic 
levels through the secretion of antimicrobial peptides43. Due to the sterility of the 
mucous layer protecting the apical surface of IECs, it is unclear how NOD2 is 
activated by non-invasive commensals. Theoretically, non-pathogenic strains are 
able to penetrate the mucous layer, where they come in contact with IECs, but this 
has rarely been seen in healthy animals. It is more likely that peptidoglycan shed 
from replicating bacteria passes through the mucous layer and onto the IECs. In 
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fact, radiolabelled peptidoglycan, in mice gavaged with [3H]DAP-labeled E. coli, is 
detectable in the serum44. Engaging NOD2 has been shown to drive TH2—type 
immune responses to pathogens including Yersinia pseudotuberculosis, Listeria 
monocytogenes, Citrobacter rodentium, Staphylococcus auerus, Salmonella spp. 
and E. coli45-47. However, pathogens such as L. pneuphila have adapted to prevent 
the degradation of peptidoglycan into MDP, and thereby avoid detection by NOD248.  
Furthermore, NOD2 signaling is protective against hypoxic stress, likely 
through inhibition of TLR4 expression, as demonstrated in a model of necrotizing 
enterocolitis49. Another study shows that MDP increases TLR2-mediated barrier 
function of murine colonic epithelial cells as measured by electric cell-substrate 
impedance sensing50. The ability of PRRs to capture MAMPs and damage-
associated molecular patterns (DAMPs) in the intestinal epithelium potentiates their 
ability to modulate the host injury response. Therefore, understanding the molecular 
underpinning of the microbiota on I/R-induced injury will yield prevention and 
treatment strategies to help maintain the integrity of the intestinal epithelium during 
the response to injury. 
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Figure 3. NOD2 expression, 
structure and signaling pathways in 
IECs.   
NOD2 expression is up-regulated by 
TNF, IFNγ, and butyrate signaling. In 
the cytoplasm, NOD2 binds its ligand, 
muramyl dipepetide (MDP), through 
leucine-rich repeats (LRRs). This 
induces a conformational change 
facilitating its oligomerization through 
its ATP-bound nucleotide-binding 
domain (NBD). Upon oligomerization, 
NOD2 recruits RIP2 kinase through its 
caspase activation and recruitment 
domains (CARD). RIP2 kinase 
activates the p38 MAPK, NF-κB and 
PI3K pathways. Conversely, the 
autophagy response at the site of 
bacterial entry is RIP2-independent 
and relies on the NOD2-ATG16L1 
interaction. RIP2 is necessary for 
downstream autophagosome 
formation. However, the contribution of 
NOD2 signaling towards the 
macroautophagy response is unknown.
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 Autophagy   1.4.
 Traditionally, the immune response elicited by the activation of NF-κB was 
thought to be the main function of NOD2 signaling. This paradigm has been 
contested, however, by recent evidence showing that microbial killing through the 
autophagy pathway is the predominant role of NOD251,52 and that antimicrobial 
peptide secretion may be independent of NOD2 signaling53.  
Autophagy is a process by which cells engulf cytoplasmic components for 
lysosomic degradation. Most of the time autophagy serves as the ‘recycling center’ 
of aged organelles. However, nutrient depravation diminishes signaling from growth 
factors, including via the insulin receptor, leading to the liberation of UNC51-like 
kinase (ULK1) from the mTOR complex 1. ULK recruits the PI3K complex, Beclin1 
and Vps15 to catalyze the nucleation of the autophagic membrane, which engulfs 
cytoplasmic organelles in an autophagosome54 . The autophagosome is decorated 
with the membrane bound microtubule-associated protein light chain 3 (LC3) that 
distinguishes this organelle from other double-membraned structures. The 
autophagosome then fuses with a lysosome, becoming an autolysosome, and the 
contents are degraded55.  
In contrast to macroautophagy, the autophagy pathway in which NOD2 
participates is crucial for clearance of microbial pathogens termed xenophagy. Some 
pathogens have adapted to evade this cellular tactic by damaging the 
autophagosome using a type-III secretion system effector proteins, and preventing 
the maturation of the autophagosome as in the case of Shigella56.  
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While various groups are able to show autophagic clearance of microbes by 
stimulating cells with MDP, the signaling pathway downstream of NOD2 is still 
unclear.  Cooney et al., for example, demonstrated that microbial clearance through 
NOD2 requires RIP2 signaling and PI3K57. Likewise, other groups have shown the 
importance of RIP2 in this pathway to promote the clearance of viral infections58,59. 
These findings contrast to the initial observations that NOD2-mediated autophagic 
clearance of S. flexneri in macrophages is independent of RIP2 function51,60. 
Therefore, the current paradigm suggests RIP2 is not necessary for the targeting of 
microbes at the plasma membrane, but it is necessary to induce autophagosome 
formation.  
Importantly, xenophagy involves the interaction between NOD2 and 
ATG16L1, another important gene associated with Crohn’s disease susceptibility61. 
Disruption of this interaction by the point-mutations seen in Crohn’s disease variants 
jeopardizes the microbial clearance of Salmonella in antigen-presenting cells62. The 
interaction of ATG16L1 and NOD2 is necessary to induce the autophagy response63. 
ATG16L1 participates as an autophagy inducer in mouse and human Paneth cells64, 
in addition to its autophagy-independent role as an inhibitor of NOD2-mediated 
inflammatory responses2. Intuitively, a deficiency in ATG16L1 should increase the 
susceptibility of mice to infection. However, mice with deficient ATG16L1 expression 
are resistant to C. rodentium infection, likely due to the hyperactive inflammatory 
phenotype of these mice. Here, the authors purport that the NOD2-ATG16L1 
pathway suppresses anti-microbial activity mediated by T-helper cells and neutrophil 
infiltration65. Although it is clear from these studies that NOD2 elicits a robust anti-
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microbial response, future work is necessary to clarify the incongruences in the 
NOD2 signaling pathway that induces autophagy. In particular, the role of RIP2 and 
the contribution of NOD2 to the canonical autophagy pathway aimed to harbor the 
cell from nutrient deprivation or hypoxic stress are areas of interest.  
 Intestinal ischemia/reperfusion-induced injury 1.5.
Studies to further our understanding on the role of the gut microbiota on 
ischemia/reperfusion (I/R)-induced injury in the gut are important to clinicians in 
human and veterinary sciences due to its potential fatality, and the diverse means by 
which this condition develops. Ischemia occurs when blood supply to the small 
bowel is occluded causing an imbalance of metabolic supply and demand. 
Paradoxically, reperfusion, the restoration of blood-flow and simultaneous re-
oxygenation of the tissue, exacerbates the injury by release of host-derived 
inflammatory mediators such as IL-6, TNF and IL-1β66. As a result, other organs 
may suffer inflammatory activation, which can lead to multiple organ dysfunction 
syndrome (MODS). Various conditions can result in I/R injury including 
atherosclerosis, hypotension, blood clots, hernias, cardiac and mesenteric surgery, 
venous thrombosis and necrotizing enterocolitis. Treatment regimens for intestinal 
ischemia include antibiotics, anticoagulants and, often times, surgery66. A better 
understanding of how I/R-induced intestinal injury can be reduced or prevented will 
yield better treatments for these numerous enteropathies and potentially could 
prevent loss of human life.  Also, understanding the interplay between gut microbiota 
and intestinal injury response could open new therapeutic avenues for this 
pathology.       
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I/R-induced injury causes metabolic imbalance, leading to the activation of 
cell death programs6, autophagy67-69, and necrosis (organelle swelling and plasma 
membrane rupturing)66,70. After 30 minutes of ischemia in mice, the epithelial barrier 
is disrupted, as shown by reduced tight junction E-cadherin levels in injured tissue40. 
Disruption of the epithelial barrier function can also allow bacterial translocation into 
intestinal tissues and potentially dissemination into extra-intestinal tissues. In 
Sprague-Dawley rats, for example, lengthening the ischemic portion of injury from 45 
to 60 minutes increased bacterial translocation to the mesenteric lymph nodes, liver 
and spleen, as well as decreased the number of Paneth cells per crypt in the injured 
portion of the tissue71.  
The hypoxic conditions experienced in ischemic tissue induce ER stress 
response, measured by Xbp1 splicing, which is characteristic of IR-induced injury. 
ER stress peaks at 30 minutes after reperfusion71. Hypoxia inducible factor (HIF)-1α 
activation promotes the expression of cytoprotective mechanisms including the 
expression of TLRs72. Interestingly, in a hemorrhagic shock model of intestinal I/R-
induced injury, HIf-1a+/- mice exhibit less intestinal injury and acute lung injury 
(indicative of MODS) than wild-type (WT) mice at 3 hours post-reperfusion. In 
addition, the injured tissue of HIf-1a+/- mice also showed diminish cleaved caspase-3 
and attenuated Cox2 mRNA levels than WT mice73.  Here, HIf-1a+/- mice exhibit less 
acute lung injury than WT mice at 3 hours after reperfusion as well. Similar findings 
were shown in an I/R-induced injury model using occlusion of the superior 
mesenteric artery (SMA) on these mice74.  
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 In response to necrotic cell death caused by ischemia, neutrophils are 
recruited to the site of I/R-induced injury. Early studies demonstrated the neutrophils 
enhanced I/R-induced injury in the gut. Neutrophil depletion using antiserum and 
monoclonal antibodies, for instance, greatly reduced intestinal I/R-induced injury in 
cats relative to the controls24. Pharmacological inhibitors were also used to 
investigate the contribution of pro-inflammatory pathways towards neutrophil 
recruitment to the site of injury by measuring myeloperoxidase (MPO) activity. 
Rapamycin (2mg/kg, s.c.), an inhibitor of mTORC1, and cyclosporine A (5mg/kg, 
s.q.), an inhibitor of T-cell activation, were found to attenuate I/R-induced injury in 
Sprague-Dawley rats75. Also, inhibition of apoptosis with caspase inhibitor ZVAD (N-
benzyloxycarbonyl Val-Ala-Asp-Ome- fluoromethylketone) decreased the severity of 
injury when administered subcutaneously before and after reperfusion. In this study, 
Farber et al. also used ZFA (N-benzyloxycarbonyl Phe-Ala fluoromethylketone), a 
structurally similar molecule with no anti-caspase activity, to control for the 
administration of the drug and demonstrate the specificity of the pharmacological 
inhibitor6. Rats that were administered ZVAD directly into a 10-cm portion of the 
jejunum prior to injury demonstrated reduced intestinal injury and MPO activity. 
Interestingly, recovery in these rats was associated with glucose-induced AKT and 
GSK3β phosphorylation75,76. A related study observed that inhibition of GSK3β by 
TDZD-8 (1mg/kg) prior to injury reduced MPO activity, production of TNFα and IL-1β 
and subsequent injury in the rats. Inhibition of GSK3β increased IkB-α degradation 
and decreased phosphorylation of NF-κB p65 in the injured tissue77. From these 
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studies, the inhibition of pro-inflammatory and pro-apoptotic pathways was shown to 
promote epithelial restitution after intestinal I/R-induced injury.  
The role of NF-κB signaling has been studied extensively in intestinal I/R-
induced injury. One study showed that the blockade of NF-κB signaling by inhibiting 
the phosphorylation Ser32 and Ser36 on IκB-α using inhibitor BAY 11-7085 (25 mg/kg 
ip) reduced I/R-induced injury, relative to the controls, 30 minutes after reperfusion. 
Here, injured small bowel showed decreased Il-6 mRNA levels and MPO activity. 
Interestingly, administration of the BAY 11-7085 exacerbated injury 6 hours after 
reperfusion78.  On the other hand, the administration α-melanocyte-stimulating 
hormone, which inhibits IκB-α tyrosine phosphorylation79 did not have the same 
effect as Bay 11-7085. The authors suggested that serine phosphorylation is 
necessary for NF-κB-mediated post-ischemic epithelial repair78. Another group found 
that NF-κB signaling increased injury in lung tissue resulting from I/R-induced injury 
to the gut. IEC-specific ablation of IκB kinase (IKK)-β, using a tissue-specific 
knockout mouse of IKK-β, reduced systemic inflammation but increased post-
ischemic injury to the intestine, consistent with previous findings suggesting that NF-
κB plays a role in the late stages of epithelial restitution80. Taken together, these 
studies suggest that cell death programs, and pro-inflammatory pathways such as 
the NF-κB and the GSK3β pathway recruit neutrophils to the site of injury, 
exacerbating the injury response in the gut and in remote sites such as the lung. 
 In addition to inflammatory pathways, the classical complement pathway is an 
important player in the host response to intestinal I/R-induced injury. IgM and IgG 
initiate this pathway, which detect ‘neo-antigens’ that lead to the processing of 
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complement component C3. C3 is cleaved by C3 convertase into anaphylatoxin C3a 
and opsonin C3b which help clear foreign cells by triggering the degranulation of 
mast cells and ‘tagging’ foreign cells for phagocytosis, respectively81. Hill et al. 
pioneered this avenue of research by reporting that the degradation of C3, by 
soluble complement receptor 1, attenuated gut I/R-induced injury. Studies on C3-/- 
mice showed a reduction in intestinal permeability after injury, although the authors 
did not quantify the injury in these mice using a scoring system82. Complement 
receptor 2-deficient mice were also resistant to injury. However, the administration of 
IgM and IgG, as well as antibodies against charged phospholipids, such as 
cardiolipin, or other natural antigens like β2-glycoprotein I, restored injury to the level 
of the wildtype controls83,84. These studies demonstrate that the complement system 
contributes to intestinal I/R-induced injury through the classical pathway.    
The study of platelets in intestinal I/R-induced injury expanded the work on 
the complement pathway because platelets were found to contribute to remote 
tissue damage following complement deposition85. After reperfusion, activated 
CD145+ platelets increase their affinity for vascular endothelia through their 
interaction with integrins and Kindlin-366, promoting the release of pro-inflammatory 
and pro-coagulating factors. Lapchak et al. demonstrated that CD145+ platelets and 
Platelet Factor 4 (PF4) exacerbate intestinal and remote acute lung injury. Pf4-/- mice 
were protected from intestinal I/R-induced injury and remote lung injury, but this 
effect was independent of immunoglobulun and complement deposition. Platelets 
from Pf4-/- were unable to induce injury in platelet-depleted WT mice. However, PF4-
mediated injury was rescued in platelet-depleted Pf4-/- transfused with WT 
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platelets86. Together, these findings indicate the activation of the complement 
cascade and subsequent platelet recruitment increases the severity of intestinal I/R-
induced injury.  
In addition to the innate immune response, I/R-induced injury elicits the 
recruitment of adaptive immune cells such as CD4+ T-cells. Infiltration of these 
immune cells peaked after an hour of reperfusion in the murine gut, but are no 
longer observed after 3 hours. Depletion of T-cells using anti-CD4 antibodies 
resulted in a reduction in the severity of injury, which was restored in mice that 
received a T-cell transfer before injury23. These cells were shown to co-localize with 
IL-17, suggesting the TH17 subset likely participates in injury. Furthermore, mice 
deficient in the IL23 subunit p19 were protected from injury. IL-17, necessary for the 
production of pro-inflammatory cytokines and chemokines (IL-6, IL-8, CXCL1, 
CXCL10), likely recruits neutrophils to the site of injury23. Although the participation 
of other adaptive immune components, such as intraepithelial lymphocytes, requires 
further study, it likely that this cellular compartment exacerbates the host injury 
response.  
 Microbial signaling and microbes in intestinal I/R-induced injury 1.6.
Multiple studies have demonstrated the role of TLRs in intestinal I/R-induced 
injury. DAMPs, damage-associated molecular patterns, are released by necrotic cell 
rupture during I/R-induced injury. MAMPs and DAMPs signal through PRRs and 
modulate the outcomes of colitis87, radiation88, and I/R-induced injury89. For 
instance, histone proteins and high-mobility group box 1 (HMGB1) are typically 
found in intracellular compartments. Upon necrotic cell death, these DAMPs are 
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released and detected by TLR4 on neighboring cells which causes apoptosis, 
autophagy and the release of pro-inflammatory mediators29,90. As a result, TLR 
signaling impairs enterocyte migration, and delays mucosal restitution during injury34-
36,73. The outcomes of these mechanisms are also reflected in studies showing the 
augmentation of TLR signaling in oxidative stress91 and the exacerbation of 
hepatic92 and lung71,93 I/R-induced injury.  
Studies on the effects of TLRs on I/R-induced injury have focused on TLR2 
and TLR4. TLR2-deficient mice exhibited worse injury than WT mice 1.5 hours after 
reperfusion. Tlr2-/- mice also demonstrated decreased Il-6 and Il-4 mRNA levels in 
the injured tissue relative to tissue from sham-operated controls94. Early studies on 
the role of TLR4 in I/R injury showed TLR4 expression is reduced after 30 minutes of 
ischemia40. However, after extensive ischemic damage (100 minutes), time-
dependent TLR4 protein expression increased starting at 1 hour post-reperfusion95. 
In addition, an increase in MPO activity was observed, and chemokine expression of 
MIP-2 and MCP-1 was increased in the injured tissue relative to the sham-operated 
controls. Mice insensitive to endotoxin, Tlr4lps-def and Tlr4lps-n, also showed resistance 
to I/R-induced injury.  In the injured tissue of these mice, pro-inflammatory cytokine 
and chemokine expression, including IL-6, TNFα and KC, were lower relative to the 
controls96. COX2 was also expressed in a TLR4-dependent manner in injured small 
bowel. The inhibition of COX2 by NS-398 attenuated injury in WT mice, but not in 
Tlr4lps-def mice96. A similar study measuring the impact of intestinal ischemia on acute 
lung injury noted that, 6 hours after injury, TLR4-deficient mice displayed attenuated 
acute lung injury and vascular permeability. These observations were accompanied 
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by decreases in TNFα, IL6, and MIP-2 cytokines levels in the lung and reduced 
neutrophil infiltration as measured by MPO activity, relative to the WT controls97.  In 
contrast, two-week-old Tlr4-/- showed greater injury and caspase-3 activity than the 
WT controls89. From these studies, it is clear that TLRs contribute to intestinal injury 
during the ischemic phase of injury. However, the contribution of TLR signaling 
towards the later stages epithelial recovery, likely through NF-κB, remains 
unaddressed. 
Studies on the TLR effector proteins, MYD88 and TRIF, have added to the 
growing body of knowledge studying the role of microbial signals on the host injury 
response. Two studies have demonstrated that Myd88-/- (C57Bl/6) mice were 
resistant to I/R-induced intestinal injury relative to the controls96,98. Trif-/- mice, 
however, demonstrated injury comparable to the WT controls96.  Interestingly, 
Helicobacter pylori infection attenuates injury in Trif-/- mice, but not Myd88-/- mice, 
suggesting that pathogens modulate host response to injury through a TRIF-
dependent pathway.  Moreover, Myd88-/- mice (Balb/c) demonstrated less MPO 
activity and inflammation in the injured gut and lungs than the WT controls after I/R 
and were able to survive longer post-reperfusion99. In addition, IRAK1, a down 
stream effector molecule of MyD88, was found to be upregulated in hypoxic 
conditions in IECs and enhanced TLR4-dependent injury during the ischemic phase. 
By suppressing IRAK1 expression through miR-146a, injury can be reduced100. A 
study on the MAP kinase pathway, downstream of MYD88, demonstrated that the 
JNK and p38 MAPKs were activated in injured tissue. The inhibition of JNK and p38 
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using LL-Z1640-2 (20mg/kg) decreased the severity of injury 60 minutes after 
reperfusion101. 
To study the role of microbes, mice were administered broad-spectrum 
antibiotics (ampicillin, vancomycin, neomycin and metronidazole) for four weeks and, 
concurrently, were administered LPS in the drinking water (10g/L) for three weeks 
before I/R injury. Mice administered only antibiotics showed augmented caspase-3 
activity and intestinal permeability 2 hours after reperfusion relative to untreated 
controls. Surprisingly, mice administered LPS in addition to antibiotics showed 
reduced intestinal permeability during injury and also reduced NF-κB DNA-binding 
activity. Injury in this model was, in part, due to TNFα since Tnfrsf1a-/- mice show 
attenuated injury even when treated with a similar cocktail of antibiotics102. A similar 
study on neonatal mice administered streptomycin sulfate (4.8 g/L), ampicillin 
(1.2g/mL), metronidazole (1.2g/L), and vancomycin (0.6g/L) in the drinking water 
prior to injury did not show an increase the severity of I/R-induced injury89. On the 
other hand, Yoshiya et al. reported the antibiotics ampicillin (1g/L), vancomycin (0.5 
g/L), neomycin sulfate (1 g/L), and metronidazole (1 g/L), administered to mice in 
drinking water for four weeks, decreased intestinal injury.  Theses mice also 
displayed lower expression of Tlr2 and Tlr4 mRNA in the injured gut and decreased 
pro-inflammatory cytokine mRNA levels of Tnf, Il6 and Cox-2. The discordant results 
from these studies suggests that antibiotics interfere with the immune response to 
injury103, therefore, germ-free mice should be used to interrogate how microbes 
participate in intestinal I/R-induced injury.  
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The only study demonstrating changes in the microbial composition during 
intestinal I/R-induced injury reported that the biggest change in microbial 
composition occurs at 12 hours post-reperfusion in rats. At this time-point, there is a 
significant bloom of E. coli, with a concomitant reduction in Lactobacilli. Interestingly, 
tissue damage is most significant at 3 hours post-reperfusion, suggesting that 
microbial changes are not driving the extent of host injury. By 72 hours post-
reperfusion, intestinal recovery and the microbial composition resembles the sham-
operated control 104.  
 
 Our model of I/R-induced injury 1.7.
Before surgery we sterilize our instruments in the autoclave and use a 
bactericidal scrub to clean our hands. Then, we prepare the murine patient for 
surgery by removing hair from the surgical site followed by a germicidal povidone-
iodine scrub followed by a 70% isopropyl alcohol rinse. The surgical area is draped 
with sterile drapes to prevent contaminants from entering the surgical field and 
provide a sterile area on which to lay sterile instruments during surgery. Prior to 
surgery, mice are placed under deep anesthesia using isoflurane (2-3%) delivered in 
oxygen using a vaporizer (Figure 4, panel 1). A pre-emptive dose of 10mg/kg, s.c., 
ketamine, per mouse is given to prevent wind-up of the pain-cascade. Opiates, such 
as buprenorphine, are not used in this study because we have shown that they 
reduce injury through mu-opioid receptor signaling derived from intestinal epithelial 
cells105. To prevent corneal desiccation, bland ophthalmic ointment is placed in the 
eyes immediately following anesthetic induction. Mice are closely monitored through 
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the ischemia procedure and internal body temperature is monitored using an internal 
probe (anal).  A heated blanket provides heat to maintain proper body temperature. 
 Once anesthetized, the peritoneal cavity is opened by midline laparotomy 
approximately 3-5 cm incision and the superior mesenteric artery is exposed. In this 
model, segmental intestinal ischemia is being induced in vivo by occluding a first-
order branch of the superior mesenteric artery (SMA) and by selectively ligating 
terminal collateral branches for 30 minutes to 1 hour with a microvascular clamp. 
(Figure 4, panel 2-3). After ischemia, the clamp is removed and we close the 
abdominal wall using an absorbable vicryl suture use 9mm stainless steel wound 
clips (staples). The animals are transferred into a new and clean cage placed under 
½ of the cage.   
After the reperfusion time period, mice are euthanized by CO2 overdose 
followed by cervical dislocation.  Intestines will be harvested for gross, histologic, 
and biological (myeloperoxydase and cytokine levels) and assessment of 
inflammation/tissue damage.  Samples from the ileum will be collected to evaluate 
Assessment of inflammation and tissue damage will be determined by blinded gross 
and histologic scores as shown in the third row of Table 2. 
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Figure 4.  Our model of intestinal I/R-induced injury.  
1. Mice are placed under deep anesthesia using isoflurane (2-3%) delivered in 
oxygen using  a vaporizer for the procedure. A pre-emptive dose of 10mg/kg, s.c., 
ketamine, per mouse is given to prevent wind-up of the pain-cascade. 2-3. The 
peritoneal cavity is opened by midline laparotomy approximately 3-5 cm incision and 
the superior mesenteric artery is exposed. In this model, segmental intestinal 
ischemia is being induced in vivo by occluding a first-order branch of the superior 
mesenteric artery (SMA) and by selectively ligating terminal collateral branches. 
 
1. 2. 3.
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CHAPTER 2 : EPITHELIAL CELL SPECIFIC MYD88 SIGNALING MEDIATES 
ISCHEMIA/REPERFUSION-INDUCED INTESTINAL INJURY INDEPENDENT 
OF MICROBIAL STATUS2 
 
 
 Introduction 2.1.
The TLR/MyD88 signaling pathway has been shown to mediate protective 
functions during intestinal exposure to various noxious events. The goal of this study 
was to define the role of bacteria and Myd88 signaling in intestinal response to 
damage using an ischemia/reperfusion (I/R)-induced injury model. We showed that 
conventionalized mice displayed a better outcome to I/R-induced injury than germ-
free (GF) mice (3.8± 1.98 vs. 11.8+1.83, p<0.05). However, mice with intestinal 
epithelial cell (IEC)-specific deletion of Myd88 (Myd88IEC-/-) were protected from I/R-
induced injury compared to Myd88f/f control mice. Myd88IEC-/- mice also displayed a 
significantly reduced bacterial translocation (~85%) into lymph nodes compared to 
Myd88f/f mice. Expression of Ccl2 and Cxcl1 mRNA was significantly reduced (85% 
and 62% respectively) in intestinal tissue of Myd88IEC-/- mice compared to Myd88f/f 
mice.
                                            
2 Published in Inflammatory Bowel Diseases, 19(13), 2857–2866. 
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Decreased expression of chemokines associated with a reduced number of 
myeloperoxidase (MPO)-positive cells in intestinal tissues of I/R-exposed
Myd88IEC-/- mice. IHC analysis showed a reduced IgA deposition and complement 
staining in ischemic tissue of Myd88IEC-/- mice compared to Myd88f/f mice. These 
findings suggest that I/R-induced intestinal injury involves IEC-derived Myd88 
signaling leading to increased IgA deposition/degradation, and complement 
activation in conjunction with an influx of neutrophils mediated by chemokine 
production.  
 Background 2.2.
The intestinal epithelium constitutes a crucial physical barrier separating the 
host from the luminal compartment containing various noxious agents such as 
bacteria, bacterial products and food-derived particles106-108. In addition to its barrier 
function, the intestinal epithelium responds to numerous bacterial stimuli through the 
action of various conserved innate sensors such as Toll-like receptors (TLRs)29.  In 
the case of commensal bacteria this dialogue between the microbiota and IECs is 
important for the maintenance of intestinal homeostasis through the induction of anti-
microbial peptides, toning of the innate and adaptive immune responses and the 
fortification of the barrier109. A compromised intestinal barrier could have deleterious 
consequences for the host as luminal contents may gain access to the mucosal 
immune system and enter the systemic circulation, triggering a damaging immune 
cell response.  The epithelium is constantly facing injury caused by various luminal 
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irritants but these episodes rarely lead to life threatening situations because the host 
has developed an efficient adaptive wound-healing response to maintain 
homeostasis110.  However, extreme challenges such as hypoxic, ischemic or 
radiation events often overpower the wound-healing response, thereby exposing the 
host to damaging luminal products.  For example, intestinal ischemia can lead to 
sepsis through bacterial translocation111 Intestinal ischemia-reperfusion (I/R) injury 
can occur under several clinical conditions like sepsis, hemorrhage, mesenteric 
ischemia due to blood clots, neonatal necrotizing enterocolitis and even small bowel 
transplantation112. Reperfusion after ischemic events causes epithelial cell death and 
disruption of barrier function leading to invasion of bacteria98. Antibiotic use is the 
mainstay of treatment to prevent sepsis from bacterial translocation after intestinal 
ischemic events103. 
Interestingly, the microbiota seems to play a protective role in various 
experimental injury models including DSS and radiation87,88,113. In contrast, global 
deletion of myeloid differentiation primary response gene (MyD88), a adaptor protein 
in innate immune signaling, protects mice from I/R-induced injury99. Moreover, in a 
model of necrotizing enterocolitis (NEC) in newborn mice, TLR/MyD88-mediated 
intestinal injury appears to be controlled by nucleotide-binding oligomerization 
domain-2 (NOD2) signaling49. However, the role of microbes in injury response to I/R 
is still unclear since most studies linking bacteria to I/R response have utilized 
reduction strategy (antibiotic treatment) and/or innate sensor-deficient mice.  
Numerous cells including IEC and mucosal immune cells expressed MyD88 and the 
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cell type specific function of this molecule in I/R-mediated injury response is 
unknown.  
In this study we investigated the impact of the microbiota using germ-free and 
conventionalized mice and defined the role of IEC-specific Myd88 signaling in I/R-
induced intestinal injury.  We report that IEC-derived Myd88 signaling promotes I/R-
induced injury. This deleterious effect is likely mediated by two main events, 1) IEC-
dependent Myd88 signaling leading to increased amount of luminal IgA and 
subsequent complement activation during the ischemic phase and 2) IEC-Myd88-
dependent expression of neutrophil chemoattractants in IECs, further damaging 
intestinal tissue.   
 Materials and Methods 2.3.
Generation of Myd88IEC-/- mice 
All mice were on a C57BL/6 background.  Villin-Cre transgenic mice were crossed to 
MyD88f/f mice (a generous gift from Dr. Anthony DeFranco, UCSF, CA), which 
contain loxP sites flanking exon 3 to generate mice lacking exon 3 of Myd88 gene in 
intestinal epithelial cells (Myd88IEC-/-)114. Tail snips were collected from all pups 
generated from crosses, and genomic DNA was isolated using a Qiagen Blood and 
Tissue Kit (Qiagen; Valencia, CA).  Primers used for genotyping were as followed:  
Villin-Cre promoter (5’-GCGGTCTGGCAGTAAAAACTATC-3’, and 5’-
GTGAAACAGCATTGCTGTCACTT-3’); MyD88f/f   (5’-GTTGTGTGTGTCCGACCGT-
3’ and 5’-GTCAGAAACAACCACCACCATGC-3’).   
For phenotypic analysis, RNA was isolated from IEC and splenocytes as previously 
described115, and expression of MyD88 was determined by PCR.  Amplicons were 
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resolved on a 2% agarose gel and visualized using a Kodak Gel Logic Imager 200 
series (Kodak; Rochester, NY). Myd88 primers used were as followed: (5’- 
TTGGATGCCTGGCAGGGG -3’), (5’-TCCTTCTTCATCGCCTTG -3’). The amplicon 
length including exon 3 was 565bp and the amplicon length without exon 3 was 
384bp. Deletion of exon 3 in epithelial cells was also confirmed by sequencing of the 
PCR products. Purity of IEC and splenocytes isolation was confirmed by amplifying 
the IEC-specific gene product Villin and the immune cell-specific marker 
(neutrophils, monocytes, B-cell subtypes) CD11b using the respectively set of 
primers (5’-CCCCCATCTTCCAACAAT -3’), (5’-GGACCTGAAATAGCCTCGTAG-3’) 
(amplicon length: 546bp) and (5’-GGCGCTGTCTACATTTTTTAT-3’), (5’- 
GCTCCCCAACCAGTGTATAAT-3’) (amplicon length 574bp) (Suppl. Figure 1). 
Ischemia/reperfusion induced injury 
Myd88f/f, Myd88IEC-/- and Myd88-/- mice (C57BL/6 background) were maintained in 
standard housing cages in specific pathogen free (SPF) conditions. To study the 
impact of the microbiota on I/R injury, one cohort of germ-free (GF) wild-type (WT) 
mice (C57BL/6 background) was transferred to specific-pathogen free (SPF) 
conditions for 4 weeks and another cohort was kept in GF conditions.  For all 
experiments, mice (n=3-5) were anesthetized under 1% isofluorane, supplemented 
by 10 mg/kg ketamine and 0.1 mg/kg buprenorphine both injected subcutaneously 
(s.c.). A mid-line laparotomy was made and peripheral branches of the superior 
mesenteric artery were occluded with aneurysm clips with a force of 50g  (Kent 
Scientific; Torrington, CN), to create a 3-5 cm region of ischemic ileum adjacent to 
the cecum.  Collateral blood flow through the intestine was blocked using aneurysm 
  
 49 
clips across the intestine and collateral vessels, demarking the region of ischemic 
intestine.  Haematoxylin was administered to the edges of ischemic tissue to mark 
them, and then the incision was closed with surgical staples.  Ischemia was 
maintained for 60 minutes, and then the incision was re-opened and the clamps 
were removed and the incision was re-closed. We have optimized this protocol to 
maximize injury and maintain a low mortality rate (4%) as previously published105.  
The mice were maintained in a heated room for a variable amount of time (0, 1.5, or 
4 hours) without anesthesia for the reperfusion phase of injury. To account for any 
systemic reaction to injury, healthy tissue adjacent to injured tissue was harvested 
as an internal healthy control as previously described105. This approach was used in 
lieu of ‘sham’ animals, which do not appropriately control for the systemic effects 
that originate from I/R-induced injury.All animal experiments were approved by the 
Institutional Animal Care and Use Committee of the University of North Carolina at 
Chapel Hill.   
Murine sample collection and histological evaluation 
Mice were anesthetized using isoflurane, and then sacrificed by cervical dislocation.  
The colon was dissected and flushed with ice-cold PBS, longitudinally splayed, 
swiss rolled, fixed in 10% formalin for 24 hrs, and then embedded in paraffin.  
Damage severity was evaluated using Haematoxylin and Eosin (H&E)-stained 
sections by an investigator blinded to the experimental conditions. The scoring 
system is based on an IEC apoptosis/necrosis system, where a score of 1 signified a 
loss of only the villus tips; a score of 2 corresponded to loss of 50% of the villus; a 
score of 3 indicated a loss of the entire villus, but with maintenance of the crypt; and 
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a score of 4 signified complete loss of the epithelial layer116. The ischemic tissue 
was divided into 4 quarter, a score was given to each quarter separately and then 
added to generate a final damage score. 
Immunohistochemistry and immunofluorescence  
IHC staining was performed according to the manufacturer’s specifications, as 
previously described115.  Primary antibodies and dilutions were as followed: 
Myeloperoxidase (MPO), 1:400 (Neomarkers, Fremont, Ca), pIgR, 1:50 (R&D 
Systems; Minneapolis, MN), IgA , 1:1000 (R&D Systems; Minneapolis, MN) and 
complement 3d, 1:50 (R&D Systems; Minneapolis, MN). IHC for activated caspase 
3, 1:400 (R&D Systems; Minneapolis, MN) was performed as described117.  All 
sections were counterstained with H&E.  
RNA isolation and real-time PCR 
RNA isolation from ileal tissues and subsequent cDNA amplification and analysis 
was performed as previously described115. Specificity and linearity of amplification 
for each primer set was determined by melting curve analysis and calculation of the 
slope from serial diluted samples. Relative fold-changes were determined using the 
ΔΔCT calculation method. Values were normalized to the internal control GAPDH or 
β-actin.  Primers: GAPDH (5’-GGTGAAGGTCGGAGTCAACGGA-3’ and 5’-
GAGGGATCTCGCTCCTGGAAGA-3’), β-actin (5’-
TGGAATCCTGTGGCATCCATGAAAC-3’ and 5’- 
TAAAACGCAGCTCAGTAACAGTCCG-3’), cxcl1 (5’-
GCTGGGATTCACCTCAAGAA-3’ and 5’- TCTCCGTTACTTGGGGACAC-3’), ccl2 
(5’-GCTGCTACTCATTCACTGGCAA-3’ and 5’- TGCTGCTGGTGATTCTCTTGTA-
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3’), tnf (5’-ATGAGCACAGAAAGCATGATC-3’, and 5’- 
TACAGGCTTGTCACTCGAATT-3’). 
Bacterial translocation and culture  
For all bacterial translocation assays, mice were subjected to 60 minutes of ischemia 
followed by 4 hours of reperfusion.  Mice were sacrificed and 2 mesenteric lymph 
nodes adjacent to the damaged tissue harvested and weighed.  The homogenates 
were lysed in 1ml PBS using a Mini Bead Beater 8 (Biospec; Bartleville, OK) and 
plated on sheep BHI plates (Remel, Lenexa, KA) and incubated in aerobic and 
anaerobic conditions for 24 hours, at which time colonies were counted. 
Statistical Analyses 
Unless specifically noted, statistical analyses were performed using GraphPad Prism 
version 5.0a (GraphPad, La Jolla, CA).  Comparisons of mouse studies were made 
with non-parametric, ANOVA and then a Mann-Whitney U test. All graphs depict 
mean ± S.E.M.  Experiments were considered statistically significant if p<.05.  
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 Results 2.4.
Commensal microbes alleviate I/R-induced ileal damage 
Although wide spectrum antibiotic treatment attenuates I/R-induced intestinal 
injury in mice, this experimental approach may have confounding effects on the 
host103. To stringently evaluate the impact of bacteria on intestinal injury response, 
we used GF and conventionalized wild-type mice. Conventionalized mice and GF 
mice (3-5 mice per group) were exposed to either 60 minutes ischemia (I) or 60 min 
ischemia followed by 180min reperfusion (I/R) and tissue injury was assessed by 
histological analysis. Although no difference was observed between the histological 
damage scores of the conventionalized and GF group (12.7±1.80 vs 11.6±0.70, 
respectively) in the ischemic phase (Figure 5 A,B), a significant improvement was 
noted in conventionalized mice versus GF mice (3.8±1.98 vs. 11.8±1.83, p<0.05) 
during the reperfusion phase (Figure 5 A,B). This finding suggests that bacteria may 
promote beneficial responses during the reperfusion phase of I/R-induced tissue 
injury.  
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Figure 5. Colonization with commensal bacteria alleviates I/R-injury.  
Cohorts of 3-5 germ-free WT mice and 5 conventionalized WT mice were subjected 
to either 60min ischemia only (I) or 60min ischemia followed by 180 min reperfusion 
(I/R). Scale bars = 200µm. (A)  Representative images of H&E stained ileal sections 
are shown. (B) Histological intestinal damage scores are depicted as means +SEM; 
p<0.05. 
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IEC-specific Myd88 deletion alleviates I/R-induced injury. 
To assess early stages of epithelial cell damage and recovery during I/R, the 
reperfusion time was reduced from 180 min to 90min for the subsequent 
experiments. We have previously optimized I/R-induced injury to maximize epithelial 
damage, but to foster survival and recovery105. To define the role of bacteria in I/R-
mediated injury, we selectively deleted Myd88 in IEC by crossing Myd88f/f mice to 
Villin-Cre mice to generate Myd88IEC-/- mice. The extent of ischemia-induced 
intestinal injury was equal in Myd88f/f and Myd88IEC-/- mice (8.8± 0.86 vs. 
10.8± 1.16; n.s.) during the ischemic phase (Figure 6A).  However, after 90 minutes 
of reperfusion Myd88IEC-/- mice showed greater epithelial restitution compared to 
Myd88f/f mice (4.6± 1.29 vs. 10± 1.67, respectively; p<0.05) (Figure 6B). The 
protective recovery observed in Myd88IEC-/- mice was similar to that of Myd88-/- mice  
(4.6± 1.29 vs. 4± 1.27, respectively) suggesting that MyD88 signaling from the IEC 
compartment was mainly responsible for the phenotype.  
Since defective IEC-derived MyD88 alleviated epithelial cell damage, we predicted 
that Myd88IEC-/- mice should have a diminished translocation of bacteria. As 
expected, a significant decrease of colony forming units (CFUs) in lymph-nodes was 
observed in I/R exposed  Myd88IEC-/- mice compared to Myd88f/f mice (67± 27 vs. 
452± 185; respectively; p<0.05;   Myd88-/-: 181± 121) (Figure 7).  
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Figure 6. IEC-specific Myd88 deletion protects from I/R injury. 
Myd88f/f, Myd88IEC-/- and Myd88-/- mice (n=5) were subjected to 60 min ischemia (I) 
only (A) or 60min ischemia followed by 90 min reperfusion (I/R) (B). Histological 
damage scores were evaluated on damaged ileal tissues using a modified scoring 
system. All graphs depict mean ± SEM.; * p<0.05. Results are representative of 2 
independent experiments. 
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Deletion of MyD88 signaling reduces I/R-induced apoptosis in epithelial cells.  
Intestinal tissues undergo hypoxia which contributes to IEC apoptosis and 
epithelial injury during I/R73. Consequently, I/R-induced IEC apoptosis was compared 
between Myd88IEC-/- and Myd88f/f mice by evaluating active caspase-3 using IHC 
staining. A significant decrease in the number of caspase-3 positive cells was 
observed in Myd88IEC-/- mice compared to Myd88f/f mice (6.4±2.4 vs. 26.3±0.53, 
respectively; p<0.05)(Figure 8A-B), a level similar to Myd88-/- mice (6.2±2.1). 
Healthy tissue rarely showed presence of activated caspase-3 (Figure 8A). No 
difference in epithelial cell proliferation was observed between the three genotypes 
as measured by Ki-67 staining (data not shown).  
IEC-derived MyD88 signaling promotes chemokine gene expression and neutrophil 
recruitment in I/R-injured tissue. 
Neutrophils have been linked to enhanced tissue damage in various injury 
models including I/R in the myocardium, liver and intestine24,118-120, therefore we next 
examined expression of various chemo-attractant genes involved in neutrophil 
recruitment. A significant induction of Tnf, Cxcl1 and Ccl2 mRNA expression was 
observed in I/R-exposed distal ileum of Myd88f/f mice compared to control healthy 
tissues (5.146± 1.802; 37.32± 7.119 and 31.09± 9.391 fold respectively). 
Interestingly, expression of Cxcl1 and Ccl2 was not induced in the injured tissue of 
Myd88IEC-/- and Myd88-/- mice compared to Myd88f/f mice (cxcl1: 14.11± 3.632; 
4.524± 0.846 vs. 37.32± 7.119, respectively; p<0.05)(ccl2: 4.524± 0.846; 
5.561± 1.275 vs. 31.09± 9.391, respectively; p<0.05)(Figure 9). 
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Figure 7. I/R-exposed Myd88IEC-/- mice display diminished bacterial 
translocation compared to Myd88f/f mice.  
Myd88f/f, Myd88IEC-/- and Myd88-/- mice (n=4) were subjected to 60 min ischemia and 
240 min reperfusion. 2 mesenteric lymph nodes adjacent to the affected ileal tissue 
were collected, weighed, homogenized, plated on BHI plates and cultured under 
aerobic and anaerobic conditions for 24h. Colony forming units (CFU) were counted 
and combined CFUs for aerobic and anaerobic conditions are shown. All graphs 
depict mean ± SEM.  * p< 0.05. Results are representative of 2 independent 
experiments.  
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Figure 8. I/R-exposed Myd88IEC-/- mice showed reduced apoptosis compared to 
Myd88f/f mice.  
Myd88f/f, Myd88IEC-/- and Myd88-/- mice (n=4) were subjected to 60 min ischemia and 
90 min reperfusion. (A) IHC showing active caspase-3 in ileal tissues. 
Representative images are shown of 3 independent experiments. Scale bars = 
200µm. (B) Average caspase-3 positive cells from ileal tissues of I/R-exposed 
Myd88f/f, Myd88IEC-/- and Myd88-/- mice. Data represent means ± SEM; p < 0.01. 
Results are representative of 2 independent experiments. 
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The expression of Tnf in injured tissue is the same across all genotypes. IHC 
analysis for myeloperoxidase (MPO), a marker for neutrophils, showed a ~50% 
reduction of infiltrating MPO-positive cells in injured tissue of Myd88IEC-/- mice 
compared to Myd88f/f mice (17.03± 3.08 vs. 40.13± 2.52, respectively; 
p<0.05)(Figure 10). Taken together these findings suggest that IEC-derived Myd88 
signaling promotes I/R-induced injury, and associates with elevated chemokine 
expression and neutrophil infiltration.  
 
PIgR expression and IgA deposition/denaturation is reduced in I/R-injured    
Myd88IEC-/- mice. 
Complement activation plays an important role in I/R-injury and inhibition of 
complement alleviates this pathological response121. Hypoxia-induced denaturation 
of IgA has recently been shown to activate complement through the mannose-
binding lectin pathway122. Interestingly, we observed reduced expression of IgA 
transporter polymeric immunoglobulin receptor (pIgR) in healthy tissue of Myd88IEC-/- 
mice compared to Myd88f/f mice (Figure 11). We sought to determine the level of IgA 
staining in Myd88IEC-/- mice following 60min of ischemia, a time-point where most 
“neo-antigens” are uncovered uncovered123. As expected IHC analysis showed 
decreased IgA staining in ischemia-exposed Myd88IEC-/- mice compared to Myd88f/f 
mice (Figure 12). The IgA staining pattern was predominantly observed at the tip of 
the villus of Myd88f/f mice, a region typically affected by hypoxic conditions such as 
ischemia.   
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Figure 9. I/R-exposed Myd88IEC-/- mice display lower chemokine mRNA 
expression.  
Myd88f/f, Myd88IEC-/- and Myd88-/- mice (n=5) were subjected to 60 min ischemia and 
90 min reperfusion and RT-PCR was performed on ileal tissue for ccl2, cxcl1 and tnf.  
Expression was normalized using gapdh. Fold-expression is shown from ischemia-
reperfusion injured tissues compared to healthy control tissues. Data represent 
means ± SEM; * p < 0.05; ** p < 0.01. Results are representative of 2 independent 
experiments. 
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Figure 10. I/R-exposed Myd88IEC-/- and Myd88-/- mice display impaired 
neutrophil influx compared to MyD88f/f mice.  
Myd88f/f, Myd88IEC-/- and Myd88-/- mice (n=4) were subjected to 60 min ischemia and 
90 min reperfusion and myeloperoxidase (MPO) expression was evaluated using 
IHC and positive cells were counted. Data represent means ± SEM; *p < 0.05. 
Results are representative of 2 independent experiments. 
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Moreover, the staining pattern for activated complement in damaged tissue 
paralleled the one observed with IgA (Figure 13), suggesting that complement 
activation is partly dependent on the presence of denaturated IgA. Taken together, 
these findings indicate that Myd88 signaling contributes to I/R injury at least partly 
through a higher abundance of luminal IgA that has the potential to bind to 
neoantigens in damaged tissue, leading to complement activation during 
reperfusion.  
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Figure 11. Expression of the IgA transporter pIgR is decreased in Myd88IEC-/- 
compared to Myd88f/f mice.  
 Myd88f/f and Myd88IEC-/- mice (n=5) were sacrificed and pIgR expression was 
evaluated using IHC on healthy small intestinal tissue. Representative images are 
shown of 2 independent experiments. Scale bars = 200µm. 
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Figure 12. IgA bound to ischemic tissue was reduced in I/R-exposed Myd88IEC-/- 
compared to Myd88f/f mice.  
Myd88f/f and Myd88IEC-/- mice (n=5) were subjected to 60min ischemia only and IgA 
expression evaluated using IHC. IgA staining is also shown for healthy small 
intestinal tissue of Myd88f/f mice (Healthy SI). Black arrows: Accumulation of IgA 
staining at the tip of the villi (region that is being affected first during I/R-injury). 
White arrows: IgA staining within B-cells. White stars: Staining of IgA within luminal 
debris. Scale bars = 200µm. Representative images are shown of 2 independent 
experiments. 
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Figure 13. Complement activation is impaired in I/R-exposed Myd88IEC-/- 
compared to Myd88f/f mice. 
Myd88f/f and Myd88IEC-/- mice (n=5) were subjected to 60min ischemia only and 
complement c3d expression was determined using IHC. Complement 3d staining is 
also shown for healthy small intestinal tissue of Myd88f/f mice (Healthy SI). Black 
arrows: Accumulation of complement 3d staining at the tip of the villi (region that is 
being affected first during I/R-injury and region with accumulation of IgA). White 
arrows: Complement staining in submucosal blood vessels. White stars: 
Complement staining only seen in crypts of Myd88IEC-/- mice when histological 
damage exceeds stage 2 (absence of villi but visible crypts). Scale bars = 200µm. 
Representative images are shown of 2 independent experiments. 
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 Discussion 2.5.
TLR/Myd88 signaling plays a critical role in various intestinal injury responses 
including chemical, radiation and I/R-induced injury87,96,113.  This signaling pathway 
mediates host responses to bacterial colonization/infection and depletion of intestinal 
commensal bacteria through antibiotic treatment attenuates I/R-induced intestinal 
injury103. Thus we hypothesized that bacteria utilize Myd88 signaling to mediate 
injury responses in intestinal epithelial cells.  However, intestinal injury was 
exacerbated in GF mice compared to conventionalized mice suggesting that bacteria 
protect against injury 124. The central role of Myd88 in TLR2, TLR4, TLR5 and TLR9 
signaling125 suggests that bacteria-mediated protective effects would likely be 
dependent on this signaling protein. Surprisingly, deletion of Myd88 from the 
intestinal epithelial compartment did not worsen I/R-induced injury but rather 
protected the epithelium.  This finding suggests that exacerbated I/R-induced injury 
in GF mice is due to a Myd88-independent pathway.  It is still unclear how the 
microbiota protect against I/R-induced intestinal damage.  Numerous innate sensors 
have been linked to intestinal injury responses including the Nod-like receptor 
Nod249. Nod2 seems to prevent I/R induced injury through downregulation of TLR4 
expression in epithelial cells, making these cells less susceptible to damage-induced 
apoptosis49. Alternatively, the microbiota may protect the epithelium independently of 
innate sensor signaling.  Generation of bacterial-derived products such as SCFA has 
been shown to help maintain intestinal homeostasis and responses to injury126. 
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Further studies would be required to identify the mechanism by which bacteria 
mediate protective effects following I/R exposure.   
Our observation that MyD88 signaling promotes the injury response 
independently of bacteria is in line with previous reports studying the function of 
TLR496, MYD8899 in I/R-induced injury as well as by other groups using a related 
model of intestinal injury49,90. Furthermore, we identified the epithelial compartment 
as the source of MyD88 induced tissue damage. Mice defective in epithelial-derived 
MyD88 signaling showed diminished neutrophil infiltration, reduced binding of sIgA 
to neoantigens and a subsequently reduced complement activation that correlated 
with the histological damage.     
Interestingly, other reports suggested that TLR2/MyD88 signaling protects 
against I/R-induced injury94.  The contrasting role of MyD88 in intestinal injury 
response could be due to variations in microbial communities in mice housed in 
different facilities.  Interestingly, microbial composition modulates wound-healing 
responses127. 
Neutrophil depletion has been shown to alleviate damage in intestinal I/R-
induced injury24,119. Interestingly, ccl2 and cxcl1 mRNA expression were reduced in 
Myd88IEC-/- mice compared to control Myd88f/f mice. This reduction correlated with a 
decreased infiltration of neutrophils into damaged tissue of Myd88IEC-/- mice 
compared to control Myd88f/f mice. Multiple studies have shown a positive 
association between Ccl2, Cxcl1 mRNA expression and infiltration of neutrophils into 
ischemic tissue119,128. MyD88 signaling is essential for neutrophil recruitment and 
tissue damage in myocardial I/R-induced injury118. Victoni et al. also reported 
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alleviated tissue damage in Myd88-/- mice compared to WT mice and demonstrated 
reduced neutrophil recruitment to the intestine upon I/R injury99. Therefore, 
epithelial-derived MyD88 signaling could be implicated in neutrophil recruitment and 
tissue damage through induction of chemokines such as Ccl2 and Cxcl1.  
In addition to reduced chemokine expression as seen in this study, Frantz et 
al. recently reported reduced pIgR mRNA expression in Myd88IEC-/- mice compared 
to Myd88f/f mice, leading to decreased levels of luminal sIgA129.  Mucosal antibodies 
have the potential to recognize “neo-antigens” revealed on ischemic cells and to 
activate the complement pathway, exacerbating damage during I/R-induced 
injury82,96,103,130. Increased intestinal IgA and IgM deposition following I/R injury in 
mice was previously reported103. Since Myd88IEC-/- mice have lower basal levels of 
luminal IgA we hypothesized that these mice would display diminished deposition of 
IgA in injured tissue. We focused on IgA because a previous study reported a similar 
levels of IgG and IgM but lower IgA levels Myd88-/- mice compared to WT mice131. In 
our study IHC analysis confirmed decreased IgA deposition in ischemic tissue from 
Myd88IEC-/- mice compared to Myd88f/f mice. Recently denatured IgA was shown to 
activate complement through the mannose-binding lectin (MBL) pathway and 
denaturation of IgA can be induced by the combination of acidosis and beta-
galactosidases present in ischemic intestinal tissue122. Importantly, inhibiting 
complement, specifically through the MBL pathway, prevents I/R-induced 
injury121,132. Interestingly, both IgA and complement displayed similar deposition on 
injured tissue of Myd88f/f mice, a pattern reduced in Myd88IEC-/- mice.  In contrast, GF 
mice have reduced IgA production133 and severe tissue damage, suggesting that a 
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mechanism other than IgA/complement activation mediates intestinal injury. For 
example, impaired production of cytoprotective molecules such as short-chain fatty 
acids (SCFA) in GF mice may explain their increased susceptibility to I/R injury124.    
 In summary, this study identified IEC-derived Myd88 signaling as promoting 
I/R-induced injury. We showed that IEC-derived Myd88 signaling leads to increased 
basal levels of luminal IgA and activated complement in ischemic tissue.  In addition, 
IEC-derived MyD88 controls induction of neutrophil chemo-attractants. This dual 
MyD88 dependent function is likely important for I/R-induced intestinal damage. 
These findings indicate that IEC-derived Myd88 signaling should be considered a 
central player in I/R induced injury and that therapeutic intervention could focus on 
this signaling protein.  
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CHAPTER 3 : THE MICROBIOTA PROTECTS AGAINST 
ISCHEMIA/REPERFUSION-INDUCED INTESTINAL INJURY THROUGH NOD2 
SIGNALING 3 
 
 
 Introduction 3.1.
Nucleotide-binding oligomerization domain-containing protein 2 (NOD2) is an 
intracellular pattern recognition receptor that induces autophagy upon detection of 
muramyl dipeptide (MDP); a component of microbial cell walls. The role of bacteria 
and NOD2 signaling towards ischemia/reperfusion (I/R) induced intestinal injury 
response has not been addressed. Here, we report that I/R-induced intestinal injury 
in germ-free (GF) C57BL/6 wildtype (WT) mice is worse than in conventionally-
derived (CONV-D) mice (scores: 10.7±1.5 vs 4.1±1.6, p<0.05).  Importantly, 
microbiota-mediated protection against I/R-induced intestinal injury is abrogated in 
CONV-D Nod2-/- mice and comparable to GF Nod2-/- mice. In addition, WT mice 
raised in specific pathogen-free (SPF) conditions fared better against I/R-induced 
injury than SPF Nod2-/- mice (4.5±0.3 vs. 8.6±1.4, p<0.05). Moreover, SPF WT mice 
administered MDP (i.p., 10mg/kg) were protected against I/R-induced injury 
compared to mice administered the inactive enantiomer, L-MDP, (scores: 6.6±0.9 vs 
3.3±0.8, p<0.05) an effect lost in Nod2-/- mice. However, MDP administration failed to 
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protect GF mice from I/R-induced intestinal injury compared to control (7.2±1.2 vs 
8.3±1.5, n.s.). This is likely due to the low expression of NOD2 in the intestinal 
epithelium of GF mice. Importantly, the autophagy-inducer rapamycin protected 
Nod2-/- mice against I/R-induced injury (5.8±1.2 vs 9.0±1.2, p<0.05) and increase the 
levels of LC3+ puncta in injured tissue of Nod2-/- mice. These findings demonstrate 
that NOD2 protects against I/R and promotes wound healing, likely through the 
induction of the autophagy response.  
 
 Background 3.2.
The epithelium lining the intestinal tract is composed of a single layer sheet of 
epithelial cells that provides nutrient absorption, hormone secretion, and innate 
immune sampling of luminal contents29,134. In addition, the epithelium provides a 
physical barrier between the host and gut microbes where intestinal epithelial cells 
(IECs) are stitched together by tight junctions that maintain the architecture of the 
epithelial sheet and prevent uncontrolled access of luminal content (microbes, 
dietary toxins, etc) to sub-epithelial tissues135. The epithelium is preserved by the 
homeostatic migration and proliferation of IECs from the base of the intestinal crypts 
to tips of the villi.  Events that disrupt this equilibrium could have deleterious 
consequences for the host as seen in patients experiencing intestinal ischemia66.     
Ischemia occurs when blood supply to the small bowel is occluded which 
followed by reperfusion, the return of blood floodflow, and simultaneous re-
oxygenation of the tissue. During ischemia, an imbalance of metabolic demand and 
supply results in hypoxic response with activation of HIF-1 as well as cell death 
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programs programs6, autophagy67-69and necrosis (organelle swelling and plasma 
membrane rupturing)66,70. Paradoxically, the restoration of blood-flow causes the 
release of inflammatory mediators such as IL-6, TNFα and IL-1β which exacerbate 
the injury66. As a result, extra-intestinal organs such as liver and the lung may suffer 
inflammatory activation, and fatal multi-organ dysfunction syndrome. In the clinic, 
causes of intestinal ischemia/reperfusion (I/R) induced injury include atherosclerosis, 
hypotension, blood clots, hernias, cardiac and mesenteric surgery, venous 
thrombosis and necrotizing enterocolitis.  
Nucleotide-binding oligomerization domain-containing protein 2 (NOD2) 
recently renamed NOD-LRR family with CARD 2 (NLRC2), is a pattern-recognition 
receptor (PPR) whose function is the intracellular reconnaissance of pathogen-
associated molecular patterns. NOD2 is important for the recognition of muramyl 
dipeptide (MDP) a component of peptidoglycan that is present in the cell walls of 
gram-positive and gram-negative bacteria. Loss-of-function mutations of NOD2 has 
been associated with Crohn’s Disease, pediatric Blau syndrome, and recently, in 
NOD2-associated auto-inflammatory disease136 The mechanism by which NOD2 
maintain intestinal homeostasis has yet to be clearly defined although current 
paradigm suggests an involvement of this innate sensor in controlling microbial 
composition137,138likely through expression of anti-microbial peptides from Paneth 
cells139.  In addition, NOD2 is implicated in other important biological response such 
as inflammasome activation42, and autophagy67. Importantly, in a pre-clinical model 
of necrotizing enterocolitis, NOD2 signaling was shown to protect against hypoxic 
stress through down-regulation of the TLR4 pathway49. However, the role of 
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commensal bacteria and NOD2 signaling in intestinal ischemia-reperfusion injury 
response has not been elucidated.  
A balance between innate inflammatory responses and cytoprotective 
mechanisms dictate the extent of end-organ damage during I/R injury. During injury-
induced hypoxic stress, cells undergo a pro-survival process called autophagy140. 
This autophagic response occurs upon inhibition of mTOR, thereby inducing the 
ULK1-mediated encapsulation of cytoplasmic components in a double-membrane 
(autophagosome) which is delivered to the lysosome for degradation140. In hepatic 
ischemia, autophagy has been shown to be a protective mechanism which favors 
cell survival and proliferation69, two key process in epithelial injury response. 
Interestingly, NOD2 recruits ATG16L1 to the plasma membrane to initiate 
autophagosome formation in response to MDP and at the site of S. flexneri entry51. 
However, the role of commensal bacteria-induced autophagy in the context of 
hypoxic stress and intestinal damage is currently unknown. 
Here, we investigated the role of microbes and NOD2 signaling in I/R-induced 
intestinal injury using germ-free (GF) and conventionally-derived (CONV-D) Nod2-/- 
mice.  We demonstrate that microbes are important for an efficient intestinal 
response to injury, an effect mediated by Nod2 signaling.
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 Materials and Methods 3.3.
Mice 
WT and Nod2-/- mice (C57BL/6 background) were maintained in GF conditions at the 
National Gnotobiotic Rodent Resource Center at UNC Chapel Hill or in specific-
pathogen free (SPF) conditions in a standard animal facility. To study the impact of 
microbiome on I/R injury, cohorts of GF WT and GF Nod2-/- were split, such that one 
group was CONV-D by transfer to SPF conditions for 4 weeks, while another group 
was kept in germ-free conditions.  
 Ischemia/reperfusion induced injury 
I/R-induced injury was performed as previously described105. Briefly, mice were 
anesthetized by 2% isofluorane. To minimize pain during surgery and reperfusion, 
mice were injected with 10 mg/kg ketamine and 0.1 mg/kg buprenorphine injected 
subcutaneously (s.c.). A mid-line laparotomy was performed. Then, the peripheral 
branches of coronal mesenteric artery and collateral blood-flow were occluded using 
50g aneurysm clips (Kent Scientific; Torrington, CN) to create a 3-5 cm region of 
ischemic ileum adjacent to the cecum. Haematoxylin was used to mark the edges of 
ischemic tissue to allow harvesting ischemic tissue and adjacent healthy tissue from 
the same mouse for comparison. This control is more appropriate than the “sham” 
operated control mice, since “sham” operated mice do not undergo a systemic 
reaction to I/R-induced injury105,141. The clips were removed after 0.5 or 1 hour of 
ischemia, and the mice were maintained in a heated room for a variable amount of 
time (0, 1.5, or 3 hours) without anesthesia for the reperfusion phase of injury. Mice 
were administered MDP (Invivogen; San Diego, CA, 10 mg/kg) or the inactive 
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enantiomer L-MDP (Invivogen; San Diego, CA, 10 mg/kg) 24 hours before injury. 
Rapamycin or (LC Laboratories; Woburn, MA, 3mg/kg) or its vehicle (DMSO) were 
administered 1 hour before injury. All animal experiments were approved by the 
Institutional Animal Care and Use Committee of the University of North Carolina at 
Chapel Hill.   
Murine sample collection and histological evaluation 
Ileal sections were dissected, splayed, swiss rolled, fixed in 30% phosphate-buffered 
formalin for 24 hrs, and then embedded in paraffin.  Damage severity was evaluated 
using Haematoxylin and Eosin (H&E)-stained sections by a blinded investigator. The 
scoring system is based on an IEC apoptosis/necrosis system, where a score of 1 
signified a loss of only the villus tips; a score of 2 corresponded to loss of 50% of the 
villus; a score of 3 indicated a loss of the entire villus, but with maintenance of the 
crypt; and a score of 4 signified complete loss of the epithelial layer as previously 
described142.   The ischemic tissue was divided into 4 quarters, a score was given to 
each quarter separately and added to generate a final damage score. 
Electron microscopy 
Ileal sections were fixed in 4% paraformaldehyde overnight at 4°C. Sections were 
fixed for 1 hour in potassium ferrocyanide-reduced osmium, followed by dehydration 
through a graded series of ethanol. Then they were embedded in Polybed 812 
epoxy resin (Polysciences, Warrington, PA). Transverse 1-µm sections were cut at 
several locations along the epithelium, stained with 1% toluidine blue and 1% 
sodium borate and examined by light microscopy to confirm the region of interest. 
Ultrathin sections were cut with a diamond knife (70–80 nm thickness), mounted on 
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200 mesh copper grids and stained with 4% aqueous uranyl acetate for 15 minutes 
followed by Reynolds’ lead citrate for 8 minutes. The sections were analyzed using a 
LEO EM-910 transmission electron microscope (Carl Zeiss SMT, Peabody, MA), 
operating at an accelerating voltage of 80 kV. Digital images were taken using a 
Gatan Orius SC 1000 CCD Camera and DigitalMicrograph 3.11.0 software (Gatan, 
Pleasanton, CA). All images were acquired at room temperature. 
RNA isolation, RT-PCR and qPCR 
 RNA isolation from intestinal epithelial cells, ileal tissues and subsequent cDNA 
amplification and analysis was performed as previously described115,141. The 
following primers were used to amplify Nod2: (FWD: 5’-
CCAGCGTCTTTGGCCATTCAACAT-3’; REV: 5’-
TTGAGCTCATCCAGTGCTTGGAGT-3’). The purity of IECs was confirmed using 
IEC-specific gene product Villin (FWD: 5’-CCCACGCAAAGAACTGAAGG-3’; REV: 
5’-TCCCGTCATCCACCATTTTC-3’), β-actin (FWD: 5’- 
TTACCAACTGGGACGACATG3’; REV: 5’- CTGGGGTGTTGAAGGTCTC-3’) as 
previously described141.The PCR product was run on a 2% agarose gel. The 
following primers were used to amplify Xbp1: (FWD: 5’-
AAACAGAGTAGCAGCGCAGACTGC-3’; REV: 5’-
TCCTTCTGGGTAGACCTCTGGGAG-3')143. The PCR product was run on a 3% 
agarose gel to resolve the spliced variant. For qPCR, relative fold-changes of Il6, Il1, 
and Tnfα were determined using the ΔΔCT calculation method as previously 
described117. Values were normalized to the internal controls, β-actin and Gapdh.  
Primers: Gapdh (FWD: 5’-GGTGAAGGTCGGAGTCAACGGA-3’; REV: 5’-
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GAGGGATCTCGCTCCTGGAAGA-3’), β-actin (FWD: 5’-
TGGAATCCTGTGGCATCCATGAAAC-3’; REV: 5’- 
TAAAACGCAGCTCAGTAACAGTCCG-3’), Il6 (FWD: 5’- 
CGGAGGCTTGGTTACACATGTT-3’; REV: 5’- CTGGCTTTGTCTTTCTTGTTATC-
3’), Tnfα (FWD: 5’-ATGAGCACAGAAAGCATGATC-3’; REV 5’- 
TACAGGCTTGTCACTCGAAT-3’), Il1b (FWD: 5’- GCCCATCCTCTGTGACTCAT-3’; 
REV: 5’- AGGCCACAGGTATTTTGTCG-3’)117,144. 
Cell Culture and Immunocytochemistry 
Human colonic HCT-116 cells were grown in 60mm tissue culture dishes to 70-80% 
confluency. Cells were treated with pepstatin A (MP pharmaceuticals; Santa Ana, 
CA, 10µg/mL) and E-64-d (Peptide Instiute, 10µg/mL) one hour before exposure to 1 
hour of normoxia or hypoxia (1% O2, CoyLab hypoxic glove box) and stimulated by 
rapamycin (LC Laboratories; Woburn, MA, 5 µg/mL). Cells were fixed and 
permeabilized as previously described145. The primary antibody for LC3 (1:200, Cell 
Signaling; Danvers, Massachusetts,  #4108) was used according to the 
manufacturer’s specifications followed by FITC-conjugated goat anti-rabbit 
secondary antibody (1:1000, Invitrogen #A-11008). Images were acquired using a 
Zeiss 710 microscope and Zeiss Zen 2009 software (Carl Zeiss, Thornwood, NY). 
Then, puncta (GFP) and cells (DAPI, Vector Laboratories #H-1200) were counted 
using ImageJ software (Rasband WS., U.S. National Institutes of Health). 
Immunofluorescence 
WT healthy and injured ileal tissues were deparaffinized using ethanol and xylenes. 
Antigen retrieval was performed by using citrate buffer (pH 6) in a pressure cooker. 
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Primary LC3 antibody (Cell Signaling; Danvers, Massachusetts,  #4108, 1:200) was 
incubated overnight according to manufacturer’s specifications followed by 
AlexaFluor 647 goat anti-rabbit secondary antibody (Invitrogen; San Diego, CA,   
1:1000). DAPI (Vector Laboratories; Burlingame, CA, #H-1200) was used to 
counterstain the sections.  Imaged were acquired a Leica SPA microscope (Leica 
Microsystems Inc., Buffalo Grove, IL). Analysis of LC3 puncta was performed using 
ImageJ software (Rasband WS., U.S. National Institutes of Health), generating a 
basal cut-off of LC3 puncta (threshold: 10) then using the “Analyze Particle” feature 
for counting to generate a mean of positive pixels per cell (%)±SEM of three fields of 
view per sample146.  Note: Immunofluorescence experiments were performed using 
this secondary antibody instead of the one previously mentioned, due to the change 
in confocal microscope.  
Statistical Analyses 
Unless specifically noted, statistical analyses were performed using GraphPad Prism 
version 5.0a (GraphPad, La Jolla, CA).  Comparisons of mouse studies were made 
with non-parametric, ANOVA and then a Mann-Whitney U test. All graphs depict 
mean ± S.E.M.  Experiments were considered statistically significant if p<.05.   
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 Results 3.4.
Microbes protect WT but not Nod2-/- mice against intestinal I/R-induced injury.  
Antibiotic treatments have recently been shown to ameliorate host response 
to I/R-induced injury103.  However, antibiotic exposure disrupts a large segment of 
the microbial community, and damage epithelial barrier function, adding a 
confounding element to the approach147. To avoid this limitation, we used GF WT 
and Nod2-/- mice to test the relationship between microbes and NOD2 on I/R-
induced injury. Cohorts of GF WT and GF Nod2-/- mice were separated into two 
groups; one that remained in GF conditions and another that was CONV-D by 
transfer to a SPF housing facility for 4 weeks.  Mice were subjected to 1 hour of 
ischemia followed by 3 hours of reperfusion, at which point ischemic and healthy 
portions of the ileum were harvested for histological analysis. Even though GF and 
CONV-D mice exhibited comparable degree of injury after 1 hour of ischemia (data 
not shown), CONV-D WT mice displayed attenuated necrosis compared to GF WT 
mice 1.5 hours after reperfusion (10.7±1.5 vs 4.1±1.6, p<0.05) (Figure 1A, left 
panel). Histological representation of tissue injury showed that GF mice displayed 
mid-villus denudement of the epithelium, while CONV-D mice showed restituted, 
nascent villi (Figure 14A). Interestingly, there was no difference in injury between GF 
Nod2-/- mice and CONV-D Nod2-/- mice after I/R-induced injury (9.3±2.3 vs 9.2±2.3) 
(Figure 14B). These results suggest that microbes harbor protective function during 
I/R-induced injury. 
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Figure 14. Microbial signaling protects against I/R-induced injury. Cohorts of 
GF, WT mice and GF, Nod2-/- mice were split into two groups.  
One group remained in GF conditions while the other was CONV-D with commensal 
microbes in an SPF facility. Mice were subjected to 60 minutes of ischemia followed 
by three hours of reperfusion. Scale bars = 100 µm. Necrosis was assessed using 
an established necrosis scoring system. H, Healthy; I/R, 1 hr ischemia followed by 3 
hours reperfusion, GF; Germ free, CONV-D; conventionally-derived.  Histological 
intestinal damage scores of individual mice are depicted, (*p<0.05) and 
representative images of H&E stained ileal sections are shown of (A) wildtype mice 
and (B) Nod2-/- mice. Results are representative of 2 independent experiments, n≥4 
per group. 
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NOD2 signaling protects against I/R-induced injury.  
To test the protective capacity of NOD2 signaling, we subjected cohorts of 
WT and Nod2-/- mice raised to I/R-induced injury in presence of the NOD2 agonist 
MDP or its inactive enantiomer, L-MDP. We first performed a time-course (up to 6 
hours of reperfusion) to better define the kinetics of the I/R injury response (data not 
shown). Based on these findings, the reperfusion time was shortened to 1.5 hours to 
better evaluate the modulatory effect of bacteria and NOD2 signaling on injury 
response.  We previously utilized this timeline to measure the modulatory effect of 
the opioid agonist DALDA on I/R-induced injury105. The extent of necrosis between 
WT and Nod2-/- mice was comparable after 0.5 hours and 1 hour of ischemia (data 
not shown). However, WT mice exhibited improved recovery outcome over Nod2-/- 
mice following reperfusion (4.5±0.3 vs. 8.6±1.4, p<0.05) (Figure 15A). Importantly, 
administration of MDP (i.p. 10 mg/kg) but not the inactive enantiomer, L-MDP 
protected WT mice against I/R-induced injury (6.6±0.9 vs 3.3±0.8, p<0.05) (Figure 
15B left panel), whereas it failed to protect Nod2-/- mice (8.3±1.4 vs. 8.6±1.4) 
(Figure 15B right panel). The improved intestinal response following MDP treatment 
in the WT mice is noted by the restitution of the villi (Fig. 2C, top panels), whereas 
Nod2-/- mice showed epithelium denudement of the villi leaving only the crypts 
(Figure 15C, bottom panels). 
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Figure 15. MDP signaling protects against I/R induced injury. Wildtype and 
Nod2-/- mice were subjected to ileal ischemia 1 hour followed by 1.5 hours of 
reperfusion.  
NOD2 ligand, MDP (1 mg/kg), or its enantiomer L-MDP (1 mg/kg) was injected 
intraperitoneally in WT mice 24hrs prior to I/R exposure. Healthy and injured tissue 
was collected, ‘swiss rolled,’ and stained with H&E. Scale bars = 100 µm. Necrosis 
was assessed using an established necrosis scoring system. H, Healthy; I/R, 1 hr 
ischemia followed by 1.5 hours reperfusion. (A-B) Histological intestinal damage 
scores of individual mice are depicted (±SEM,* p<0.05) (C) Representative images 
of H&E stained ileal sections are shown. Results are representative of 3 
independent experiments, n≥4 per group.
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Microbially-induced expression of NOD2 in intestinal epithelial cells is necessary for 
protection against injury.  
A previous report showed that Nod2 expression in the intestine is lower in GF 
mice than SPF mice138. We then hypothesized that MDP-mediated protective effects 
will be ablated in GF mice due to impaired NOD2 expression. Interestingly, MDP-
administered GF mice were not protected from I/R-induced injury compared to L-
MDP controls (7.2±3.0 vs. 8.3±3.7) (Figure 16A), a phenomenon correlating with 
lack of detectable Nod2 mRNA in IECs isolated from the terminal ileum of GF mice 
(Figure 16B, right column). Transferring GF mice to the SPF condition for 4 weeks 
resulted in detectable Nod2 mRNA expression (Figure 16B), suggesting that 
bacteria regulate Nod2 expression and signaling. Taken together these results 
suggest that Nod2 expression/signaling is dependent upon commensal microbes, 
likely mediating protection against I/R-induced injury.  
 
I/R-induced injury causes hypoxic stress and autophagy in WT and Nod2-/- mice.  
Further evaluation of the injury using electron microscopy analysis showed 
cytoplasmic thinning, mitochondrial swelling, autophagosome and late endosomes 
formation, all cellular characteristics of hypoxic tissues90,148 (Fig. S2). In related 
models of I/R-induced injury, the endoplasmic reticulum (ER)-stress marker XPB1 
has been shown to accumulate in hypoxic tissues149,150.  We evaluated the 
expression of spliced Xbp1 mRNA in injured tissues from WT mice and compared it 
to adjacent healthy tissue. 
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Figure 16. Microbial induction of NOD2 expression in IECs is necessary for 
protection against injury.  
(A) Germ-free, wildtype mice were subjected to ileal ischemia for 1 hour, and 
followed by 3 hours of reperfusion. NOD2 ligand, MDP (1 mg/kg), or its enantiomer 
L-MDP (1 mg/kg) was injected intraperitoneally in mice 24hrs prior to I/R exposure. 
Healthy and injured tissue was collected, ‘swiss rolled,’ and stained with H&E. Scale 
bars = 100 µm. Necrosis was assessed using an established necrosis scoring 
system. H, Healthy; I, Ischemia only; I/R, 1 hr ischemia followed by 3 hours 
reperfusion. Histological intestinal damage scores of individual mice are depicted 
and representative images of H&E stained ileal sections are shown. (B) IECs were 
isolated from GF and CONV-D WT mice, and Nod2 mRNA level was assessed using 
RT-PCR.  Actin and Villin mRNA were amplified as loading and isolation efficacy 
respectively.   
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We observed an accumulation of spliced Xbp1 mRNA in the injured tissue of both 
WT and Nod2-/- mice (Figure 17A). In addition, cytokine expression has been used 
as an indicator of hypoxia in I/R-induced injury151, as well as in a related models of 
hypoxia in-vitro152 and in-vivo153.  Therefore, we evaluated Tnfα, Il-6 and Il-1β mRNA 
accumulation in ileal tissue of WT and Nod2-/- mice that underwent I/R-induced 
injury. As expected, I/R-induced injury increased Tnfα, Il-6 and Il-1β mRNA 
accumulation in WT and  Nod2-/- mice compared to cytokine levels in adjacent 
healthy tissue to the site of ischemia (Figure 17B).  No noticeable differences were 
observed in ER-stress response (Xbp1 or cytokines) between WT and Nod2-/- mice, 
suggesting that increased tissues damage in Nod2-/- mice (Figure 15) is not related 
to the extent of ER stress response.  
Recent studies show that hypoxic stress in the intestinal mucosa occurs 
during I/R-induced injury66 which associates with increased expression of autophagy 
marker, LC3, in the small bowel90. Therefore, we determined LC3 levels in WT and 
Nod2-/- mice exposed to I/R conditions.  At homeostasis, healthy tissue of WT and 
Nod2-/- mice show low detectable amounts of cytoplasmic LC3+ puncta. Upon I/R-
induced injury, the amount of LC3+ puncta per cell increased substantially in the 
epithelium of WT mice (37.8±10.37 puncta per cell), compared to Nod2-/- mice 
(5.0±0.4 puncta per cell) (Figure 18). Taken together, these results indicate that I/R-
induced injury is associated with ER stress and induction of autophagy, a 
phenomenon dependent on NOD2 signaling.   
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Figure 17. I/R-induced injury induces ER stress in WT and Nod2-/- mice.   
(A) WT and Nod2-/- mice were subjected to I/R-induced injury, as described above. 
RT-PCR was of ER-stress response marker, XBP1, was performed and resolved on 
a 3% agarose gel. (B) Il1b, Il6, and Tnfα mRNA from healthy and injured ileal tissue 
were determined using ABIPrism7900HT.  Data were processed using the ΔΔCt 
method, normalized to β-actin and set relative to healthy tissue. I/R, 1 hr ischemia 
followed by 1.5 hours reperfusion. Results are representative of 3 independent 
experiments. *p<0.05, n≥4 per group.  
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Rapamycin rescues autophagy-mediated protection in Nod2-/- mice, but not WT mice 
from I/R-induced injury.  
 The lack of Nod2 mRNA expression in GF IECs and increased expression of 
the innate sensor following bacterial colonization, which correlated with protection 
against I/R-induced injury suggest that these cells may be important for injury 
response.  We hypothesized that inducing the autophagy response in IEC would 
alleviate I/R-induced injury in Nod2-/- mice. We first tested whether the autophagy 
inducer rapamycin could modulate hypoxia-induced autophagy using a reductionist 
in vitro system. Rapamycin has previously been shown to attenuate I/R-induced 
injury in the gut, pancreas and heart69,154,155.  Human colonic epithelial HCT116 
cells, which constitutively expressed NOD2 were exposed to hypoxic conditions (1% 
O2) using a Coy Labs hypoxic glove box and then treated with rapamycin (500 nM) 
for 1 hr. To monitor autophagic flux, the cells were pre-treated for 1 hour with 
proteasome inhibitors E-64-d and Pepstatin A and autophagy response was 
evaluated by measuring LC3+ puncta per cell using immunofluorescence staining. 
As expected, the baseline of LC3+ puncta was elevated under hypoxic stress. 
Remarkably, hypoxic cells exposed to rapamycin displayed a strong increase in the 
number of LC3+ puncta per cell, compared to un-stimulated conditions (Figure 19A-
B).  
 To specifically determine the beneficial effect of autophagic response on I/R 
injury, we evaluated whether rapamycin could rescue Nod2-/- mice from exacerbated 
I/R-induced injury. Cohorts of WT and Nod2-/- mice were administered rapamycin 
(i.p. 3mg/kg) or vehicle (DMSO) 1 hour before I/R-induced injury and tissue damage 
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Figure 18. I/R-induced injury induces autophagy through NOD2. 
Immunofluorescence staining of LC3 was performed on paraffin-embedded 
healthy and injured ileal tissue from WT and Nod2-/- mice.  
NOD2 ligand, MDP (1 mg/kg), or its enantiomer L-MDP (1 mg/kg) was injected 
intraperitoneally in mice 24hrs prior to I/R exposure. H, Healthy; I, Ischemia only; I/R, 
1 hr ischemia followed by 1.5 hours reperfusion. (A) The average number of LC3+ 
puncta per cell in the injured and healthy portions of the terminal ileum of untreated 
WT and Nod2-/- mice and corresponding representative images of the intestinal 
epithelium of mice. Results are representative of 3 fields of view per sample. Scale 
bars = 5 µm.   
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Figure 19. Rapamycin enhances hypoxia-induced autophagy in HCT116 cells.  
HCT116 cells were treated with pepstatin A (10µg/mL) and E-64-d (10µg/mL) one 
hour before exposure to 1 hour of normoxia or hypoxia (1% O2, CoyLab hypoxic 
glove box) and stimulated by rapamycin (5 µg/mL). LC3+ puntae (GFP) and cells 
(DAPI) were counted using ImageJ software (Rasband WS., U.S. National Institutes 
of Health).  (A) Representative images of LC3+ puncta in HCT116 cells stimulated 
with rapamycin in normoxic and hypoxic conditions. (B) The average number of 
puncta per cell of cells stimulated with rapamycin in normoxic and hypoxic 
conditions, *p<0.05. Results are representative of 3 independent experiments.
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evaluated using H&E staining. Interestingly, rapamycin decreased I/R-induced injury 
in Nod2-/- mice compared to the level of injury observed in vehicle-treated mice 
(9.0±1.2 vs 5.2±1.0, p<0.05), as shown by the nascent villi of the restituted 
epithelium (Figure 20A-B). WT mice trended towards protection against injury, but 
the effect of rapamycin was marginal likely due to functional NOD2 signaling in these 
mice (data not shown). In addition, rapamycin treatment increased the number of 
detectable LC3+ puncta per cell in Nod2-/- mice (37.9±13.9 puncta per cell) 
compared to the number in vehicle-treated mice (5.9±2.0 puncta per cell) suggesting 
that NOD2 contributes to autophagy response that fosters the recovery of the 
intestinal epithelium (Figure 20C-D). Overall, our findings indicate that intestinal 
bacteria contribute to epithelial cell recovery from I/R-induced damage through 
NOD2 signaling and an improved autophagy response.   
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Figure 20. Rapamycin-induced autophagy protects Nod2-/- mice against I/R-
induced injury.  
Wildtype and Nod2-/- mice were subjected to ileal ischemia followed by 1.5 hours of 
reperfusion. Autophagy-inducer, rapamycin (3 mg/kg) or its vehicle, DMSO, was 
injected intraperitoneally in Nod2-/- 1hr  prior to I/R exposure. Healthy and injured 
tissue was collected, ‘swiss rolled,’ and stained with H&E. Necrosis was assessed 
using an established necrosis scoring system. H, Healthy; I/R, 1 hr ischemia 
followed by 1.5 hours reperfusion; Rapa, Rapamycin; Veh, Vehicle.  (A) Histological 
intestinal damage scores of individual mice are depicted (±SEM, *p<0.05).(B) 
Representative images of H&E stained ileal sections are shown. Results are 
representative of 2 independent experiments, n≥4 per group. Scale bars = 100 µm.   
(C-D) The average number of LC3+ puncta per cell and representative images of the 
intestinal epithelium of mice administered either rapamycin or vehicle. *p<0.05. 
Results are representative of 3 independent fields of view per sample. Scale bars = 
5. 
  
 93 
 Discussion 3.5.
Intestinal I/R-induced injury results from a wide range of pathological 
conditions such as inflammation, infection, atherosclerotic clots, and surgery and 
may lead to fatal multiple organ dysfunction syndrome66. Since epithelial injury take 
place in the context of a complex and rich microbiota, which significantly affect 
various intestinal functions such as innate and adaptive immune system toning, 
epithelial homeostasis and nutrient metabolism156, one could posit that microbes 
would influence injury response. Already, microbial sensors such as TLR4 have 
been linked to I/R injury response89,92, although microbial contribution to this 
phenotype has not been clearly established.  Here, we directly address this 
possibility and show that the microbiota is an essential component to optimal 
epithelial recovery from injury. Our data showed that the beneficial effect of the 
microbiota requires the presence of NOD2 in line with current findings showing that 
NOD2 engages cytoprotective programs against oxidative stress in intestinal stem 
cells41. NOD2-deficient mice, unlike WT mice, showed an exacerbated response 
even when transferred from GF to SPF conditions. Upon colonization, the microbiota 
induced the expression of Nod2 through stimulation of other PRRs that activate NF-
κB in vivo157,158 a key transcription factor involved in NOD2 expression 60,159. 
Additionally, we have observed rapid stimulation of Nod2 expression induced by 
LPS in small bowel IECs isolated from germ-free mice that were administered LPS 
(personal observation).   A similar regulatory system was shown to induce NOD2 
expression and function in other epithelial cells160.  Finally, at a mechanistic level, 
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NOD2 may be essential to activate a proper autophagic response following hypoxia 
exposure since rapamycin partially rescues Nod2-/- mice from I/R-induced injury.   
The microbiota performs multiple tasks in the gut, including pathogen 
exclusion, immune system toning and metabolic functions161. A number of reports 
demonstrate that the microbiota also contributes to various aspects of barrier 
function162. For example, germ-free animals have decreased rates of epithelial cell-
turn over in the small bowel, as well as decreased TLR and anti-microbial peptide 
expression163. In addition, GF mice exhibited heightened DSS164, radiation165 and 
thermal induced injury166 when compared to CONV-D mice.  Our findings that 
recovery from I/R-induced injury is impaired in GF mice compared to CONV-D mice 
add to the growing evidence that microbes play a protective role against a multitude 
of injury insults.  The microbiota could benefit the host against injury through a 
number of mechanisms including activation of innate signaling pathway (e.g TLR2)94 
and production of bacterial-derived metabolites such as short chain fatty acids167. 
Our findings, however, are contrary to previous studies showing the protective 
effects of antibiotics against I/R-induced injury103. This discrepancy highlights the 
complexity behind the host-microbe relationship, suggesting that perturbations to the 
existing microbial community impact the underlying signaling mechanisms that 
modulate epithelial restitution. The reduction of pro-inflammatory T-cell populations 
in the small bowel by antibiotics21, may have also contributed to the observed 
amelioration of the injury23.  Nevertheless, the extent to which antibiotics interfere 
with microbial signaling requires further study. In our study, CONV-D Nod2-/- mice do 
not show protection against I/R-induced injury relative to GF Nod2-/- mice, and MDP 
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greatly improved injury recovery in WT mice, but not Nod2-/- mice, we conclude that 
the presence of this innate sensor instead of microbial metabolites is essential for 
microbiota-mediated injury response.  
The autophagy response is the culmination of hypoxia and ER stress during 
ischemia. Hypoxia has been previously shown to be an outcome of intestinal I/R-
induced injury74. Moreover, autophagy resulting from hypoxia is a protective 
mechanism in the heart154,168 as well as in I/R-induced kidney injury169. During the 
hour-long ischemic insult, the damage to the intestinal epithelium is similar between 
WT and Nod2-/- mice. Both WT and Nod2-/- mice are able to effectively activate ER-
stress response programs, as seen by Xbp1 splicing, electron microscopy and the 
induction of inflammatory mediators Il1β, Il6 and Tnfα. However, the presence of 
NOD2 is necessary for effective epithelial restitution after ischemia, likely through 
induction of autophagy. Hypoxia-induced autophagy is potentiated by microbial 
signaling through NOD2 as demonstrated by the higher abundance of LC3 puncta in 
the epithelium of injured WT mice compared to Nod2-/- mice.  In addition, increased 
LC3+ puncta is observed in the epithelium of rapamycin-treated Nod2-/- mice, with a 
concomitant improved epithelial injury response.  The exact role of autophagy in I/R 
induced injury is not clear but could represent an essential cellular adaptation, 
maintaining cellular energy balance when access to external nutrients and oxygen is 
ablated, as in the case for ischemic tissues.  
Microbial dysbiosis has been linked to various diseases including 
inflammatory bowel diseases170 and colorectal cancer5 and one could postulate that 
the defective injury response observed in Nod2-/- mice is due to altered microbiome 
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composition.  Interestingly, DSS-induced colitis and colitis-associated colorectal 
cancer in Nod2-/- mice could be transmitted to WT mice by fecal transplantation171, 
suggesting that microbial dysbiosis in Nod2-/- mice could transfer disease phenotype. 
However, whether NOD2 signaling influences microbial composition is controversial 
since Shanahan et al. demonstrated that Nod2-/- mice and cohoused WT littermates 
displayed comparable antimicrobial (AMP) expression patterns and identical 
antimicrobial activity against commensal and pathogenic bacteria53. In addition, 
microbial composition was not influenced by NOD2 status53,172 Since we observed 
that GF Nod2-/-  and GF WT showed enhanced I/R-induced injury, it is unlikely that 
this response is due to dysbiotic microbiome. The fact that MDP partially restores 
the host response to injury in WT mice indicates that microbial products, rather than 
altered in microbial composition are responsible for the beneficial effect.      
Recently, Mühlbauer et al. showed that specific removal of MyD88 signaling 
from IECs attenuates intestinal injury, suggesting that this pathway promotes 
intestinal injury141. Since MyD88 is a key signaling protein implicated in activation of 
numerous microbial detection systems (TLR2, TLR4, TLR5 and TLR9), our finding 
that bacteria utilize NOD2 to mediate a protective function highlights the complex 
interaction between bacteria, innate signaling and intestinal homeostasis. It is likely 
that an ensemble of forward, feedback and negative signaling cascades co-exist in 
the intestine to regulate intestinal homeostasis and response to various insults 
including I/R.  Differential engagement of this complex signaling network would 
dictate the final physiological outcome (deleterious or beneficial).    
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 In summary, this study identified a protective role for microbial signaling 
through NOD2 in I/R-induced injury. The microbiota protect the intestinal epithelium 
from injury by inducing Nod2 expression and signaling in IECs, which induces the 
autophagy response. Although NOD2 deficiency worsens injury, rapamycin rescues 
epithelial restitution and the autophagy response in Nod2-/- mice. These findings 
indicate that NOD2 may induce the canonical autophagy response as a 
cytoprotective response to injury, allowing cells to survive and recover from the 
insult. Further studies using genetically engineered mice will delineate the NOD2 
signaling compartment (IEC vs immune cells) involved in injury response as well as 
define signaling molecules downstream of NOD2 by which autophagy is in this 
process.  Based on the absence of Nod2 mRNA in the IECs of GF mice and 
induction of Nod2 message in IECs following colonization, we predict that NOD2-
derived IEC signaling is the main cellular compartment mediating intestinal recovery 
to I/R-injury.
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CHAPTER 4 : DISCUSSION AND LIMITATIONS 
 
 A delicate balance between microbial signals modulates epithelial 4.1.
restitution after ischemia/reperfusion-induced injury  
The two studies presented here demonstrate that microbial signals can 
drastically change the outcomes of I/R-induced injury. On the one hand, removing 
MyD88 protects the epithelium, and on the other, removing NOD2 hinders recovery. 
Remarkably, both signaling pathways share common down-stream targets, including 
the TRAF6/TAK1 pathway that activates NF-κB, and the MAPK pathway that signals 
through p38173. Hence, it is likely that non-communal pathways of these two 
signaling proteins strongly influence the host injury response. Indeed, MyD88-
deficient mice demonstrate normal levels of IFNβ and delayed activation of NF-κB 
upon TLR4 activation. Other adaptors such as TRIF, and the consequences of their 
downstream signaling may foster epithelial restitution, contrary to the effects 
mediated-through the MyD88 pathway174. MyD88 appears to be the common 
denominator in studies showing TLR4- and TLR2-induced intestinal, cardiac and 
hepatic I/R-induced injury99,175,176.  In chapter 2, we postulated that MyD88 
potentiates injury from the IEC compartment by inducing complement activation and 
neutrophil invasion. In addition, it is likely that the absence of MyD88 is facilitating 
the overdrive of the MyD88-independent pathways such as TLR4-induced 
autophagy177, which could foster recovery.  
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In the intestine, microbial ligands can modulate basal levels of autophagy 
through TLR4 and NOD2 signaling54. In macrophages, TLR4 increases autophagy 
via TRIF following Pseudomonas aeruginosa infection177.  More importantly, the 
activation of this pathway is independent of MyD88, but requires PI3K (Class III) 
signaling and p38178, both of which are also activated by NOD239. Therefore, we 
speculate that MyD88-deficient mice may be protected against I/R-induced injury by 
the TLR4-mediated autophagy response.  
The regulation of TLR/MyD88 signaling by NOD2 is another factor that may 
explain the discordant results observed in the MyD88 and NOD2 injury studies. 
NOD2-deficient macrophages show enhanced TLR4-mediated expression of 
inflammatory cytokines179. Similarly, NOD2-deficient enterocytes show a 200-fold 
increase in TLR4 mRNA expression 49. In this study Richardson et al. show TLR4 
signaling inhibits enterocytes migration, likely dampening injury repair. Here, NOD2 
signaling reverses the detrimental effects of TLR4 the host wound-healing response 
in a murine model of necrotizing enterocolitis49. Therefore, Nod2-/- mice may exhibit 
dysregulated TLR4/MyD88 signaling, likely activating NF-kB, which has been shown 
to exacerbate intestinal I/R-induced injury78. Aside from TLR4, NOD2 also inhibits 
TLR2-mediated T-helper cell activation180, which are detrimental in I/R-induced injury 
of the heart, brain and kidneys66. In fact, NOD2 deficiency resulted in excessive TH1 
responses which were also found to cause colitis in Nod2-/- mice181. Hence, it is likely 
that dysregulated TLR2 signals also contribute to intestinal I/R in Nod2-/- mice 
through exacerbated T-cell activation. Taken together, NOD2 may attenuate 
TLR/MyD88 signaling, which benefit epithelial recovery from I/R-induced injury. 
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TLRs, in turn, also influence NOD2 expression and function. Two studies 
have noted that LPS/TLR4 signaling increases Nod2 messenger RNA expression in 
macrophages179,182. The immune response to L. monocytogenes infection from 
macrophages highly depends on NOD2. However, naïve macrophages do not elicit 
an inflammatory response as robust as those pre-exposed to TLR ligands, 
demonstrating that signaling from TLR2 and TLR4 drive NOD2 expression and 
function. In addition, work in our lab has demonstrated that germ-free mice do not 
express Nod2 in IECs. However, LPS (25 mg/kg, i.p.) administration to GF mice 
induces Nod2 message in IECs four hours after the injection (Perez-Chanona & 
Jobin, personal observation). The role of MyD88 in Nod2 expression in IECs 
remains to be tested. However, it is likely that TLR4/MyD88 signaling augments the 
protective effects of NOD2 in the host injury response. 
 Limitation and Future Directions 4.2.
A number of experimental limitations should be pointed out in this work.  
Although intraperitoneal injections to deliver MDP and engage NOD2 signaling in the 
intestine has been used by several groups49,183, the mechanism by which MDP 
reaches NOD2 in intestinal epithelial cells in our model is unclear.  Up-take of MDP 
has been shown to depend on the presence of the solute carrier family 15 member 1 
(SLC15A1), which is expressed on the brush border of IEC184.  This route would not 
be engaged by i.p. delivery, suggesting that MDP could alternatively be internalized 
by IEC through other means such as endocytosis from the serosal membrane.  
Germ-free mice are a valuable tool for interrogating the role of the microbiota 
in host 
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vascularization in the small bowel185 and reduced cellular migration186 which may 
limit epithelial restitution after I/R-induced injury. Therefore, one could speculate that 
increased injury in GF mice compared to CONV mice relates to the altered 
vascularization system instead of defective microbe/NOD2 signaling.  However, the 
fact that intestinal injury is exacerbated in CONV Nod2-/- mice compared to CONV 
WT mice demonstrates that the innate sensor, and not vascularization, is 
responsible for the phenotype. Neutrophils, which exacerbate I/R-induced injury, 
express pro-IL1β instigated by peptidoglycan signaling through NOD1 in the 
intestine and in circulation187. In addition, impaired regulatory T-cell responses in 
germ-free mice could result in unchecked pro-inflammatory responses by 
neutrophils, accounting for the exacerbated injury observed in these mice compared 
to the CONV mice188.  
The intestinal I/R-induced injury murine model is predominantly performed in 
the small bowel. A potential limitation to this approach is the applicability of our 
findings to the host injury response seen in the colon, where ischemic injury also 
occurs. In addition, it is challenging to compare our results to those of other research 
groups because factors that influence injury responses such as genetic background, 
the method of anesthesia and analgesia, the artery occlusion method, the duration 
of ischemia, and the duration of epithelial recovery after reperfusion, is quite variable 
(Table 1). Commonly used anesthetics and analgesics including opiates189, 
isoflurane190 and ketamine191 have been shown to protect against intestinal I/R-
induced injury. The inconsistency between groups in the use of these drugs may 
account for the conflicting evidence, as in the case of TLR4, in reports on the host 
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response to injury89,96. Understanding the ‘bigger picture’ in the host response to 
injury is confounded by heterogeneity in the duration of ischemia and the duration of 
the recovery period after reperfusion. The extent of protection conferred by the 
innate sensors against injury is difficult to understand, since the responses to injury 
(measured by neutrophil invasion, and cytokine expression) and epithelial restitution 
depends largely on the severity of the ischemic insult. Lastly, it is important to be 
aware of the various scoring systems used by groups in the field (Table 2) to 
understand the degree of injury in a specific setting.  For instance, in the studies by 
Watanabe et al.98 and Muhlbauer et al.141, both investigators used MyD88-/- mice and 
assigned an injury score of “4” to the small bowel of these mice.  Watanabe referred 
to this score as a significant amount of injury after I/R exposure, whereas Muhlbauer 
described a mildly injured epithelium. This highlights the subjective nature of the 
histopathological assessment of I/R injury and then need to correlate injury with 
more quantitative metrics (e.g cytokines).
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Table 1. Models of Murine Intestinal I/R-induced injury 
Murine Species Anesthesia / 
Analgesia 
Artery occlusion method Ischemia 
time 
Time after 
Reperfusion 
Ref 
Sprague-Dawley 
rats 
Sodium 
pentobarbital 
Occlusion of SMA and coelic 
trunk using aneurysm clip or 
clamp 
45 min 2 hours 77,192,1
93 
Sprague-Dawley 
rats 
Not reported Occlusion using aneurysm 
clip or clamp 
45 min 30 min or 6 
hours 
78,79 
Sprague-Dawley 
rats 
Not reported Ligation of 6-cm jejunal 
segment, and an atramuatic 
vascular clamp across the 
mesentary 
30, 45, 
and 60 
min 
30 min and 2 
hours 
71 
Sprague-Dawley 
rats 
Ketamine (40 
mg/kg) 
Occlusion using aneurysm 
clip or clamp 
1 hour 1 hour 75 
Sprague-Dawley 
rats 
Ketamine (100 
mg/kg) 
Occlusion using aneurysm 
clip or clamp 
30 min 1, 3, 6, 12, 
24, 72 hours 
104 
Sprague-Dawley 
rats 
Urathane 
(20%, 6 
mL/kg) 
Occlusion using aneurysm 
clip or clamp 
1 hour 1 or 2 hours 155 
Wistar rats Urethane (1.2 
g/kg, i.p.) 
Occlusion using aneurysm 
clip or clamp 
20 min 1 hour 76 
Wistar rats Sodium 
Pentobarbital 
(50 mg/kg) 
Occlusion using aneurysm 
clip or clamp 
30 min 30 min and 1 
hour 
101,151 
Hodded Lister 
rats 
Sodium 
pentobarbital 
(60 mg/kg) 
Stout ligatures to a 3-4 cm 
loop of the jejunum 
Two 8-min 
episodes 
30 min 
between  
episodes 
194 
Balb/c mice ketamine (100 
mg/kg, i.p.) 
and xylazine 
(20 mg/kg, 
i.p.) 
Occlusion using aneurysm 
clip or clamp 
45 min 4 hours 99 
C57B6/129 mice Sodium 
pentobarbital 
(50-70 mg/kg) 
The superior mesenteric 
artery was reversibly 
occluded at its origin with the 
aorta using 4 – 0 suture 
15 or 45 
min 
3 hours 74 
C57B6/129 Sodium 
pentobarbital 
(60 – 80 
mg/kg ip) and 
inhaled 
Isoflurane 
Blood withdrawn from the 
jugular vein until a mean 
arterial pressure (MAP) 
between 35 and 40 mmHg 
1 hour 3 hours 73 
C57Bl6/129 2% halothane Occlusion of mesenteric 
arteriole feeding 8-10 cm of 
terminal lieum. Occlusion of 
collateral circulation at the 
proximal and distal portions 
of the tissue. 
30 to 130 
min 
6 hours 6 
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C75BL/6 Sodium 
pentobarbital 
(36 mg/kg) 
Occlusion using aneurysm 
clip or clamp 
30 min 3 hours 85,86,19
5 
C57BL/6 Sodium 
pentobarbital 
(72 mg/kg) 
Occlusion using aneurysm 
clip or clamp 
30 min 4 hours 32,103 
C57BL/6 
 
Sodium 
pentobarbital 
(90 mg/kg) 
Tourniquets occluded 
mesenteric vessels to 
jejunum 
40 min 3 hours 82,196 
C57BL/6 Urathane 
(concentration 
not reported) 
Occlusion using aneurysm 
clip or clamp 
45 min 60 min 98 
C56BL/6 Inhaled 
isoflurane 
Occlusion using aneurysm 
clip or clamp 
60 min 1.5 hours 89,94 
C56BL/6 Inhaled 
isoflurane 
Occlusion of SMA and 
ileocolic artery using 
aneurysm clip or clamp 
100 min 10 min 197 
C56BL/6 Inhaled 
isoflurane 
Occlusion of SMA and 
ileocolic artery using 
aneurysm clip or clamp 
100 min 1, 2, 4, 24 
hours 
95 
C56BL/6 Ketamine         
(80mg/kg)   
and xylazine 
(10mg/kg) 
Occlusion using aneurysm 
clip or clamp 
30 min 30 min, 2 
hours, 4 
hours 
80,102 
C57BL/6 ketamine      
(16 mg/kg) 
and xylazine 
(80 mg/kg) 
Occlusion using aneurysm 
clip or clamp 
30 min 1 hour or 3 
hours 
23 
C3H/Hej Sodium 
pentobarbital 
(50mg/kg) 
Occlusion using aneurysm 
clip or clamp 
40 min 6 hours 93 
BALB/c, 
C57BL/6 
C3HeB/FeJ, 
C3H/HeJ 
C57Bl/10, 
B10/ScNJ 
Ketamine 
(16mg/kg) and 
xylazine 
(80mg/kg) 
Occlusion using aneurysm 
clip or clamp 
30 min 2 hours 83,84,96
,198,199 
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Table 2. Histology Scoring Systems in Intestinal I/R-induced injury  
Histology scoring system Reference 
Grade 1: Normal mucosal villi;  
Grade 2: Development of mucosal sloughing;  
Grade 3: Epithelial layer lifting up in sheets, presence of a few denuded 
villous tips, and mild capillary congestion 
Grade 4: Exposed lamina propria, dilated capillaries, and evidence of hemorrhage 
Grade 5: Digestion and disintegration of the lamina propria.  
6 
Grade 0: Normal mucosa,  
Grade 1: Subepithelial space at the villous tip,  
Grade 2: More extended subepithelial space  
Grade 3: Epithelial lifting along the villous sides  
Grade 4: Denuded villi  
Grade 5: Loss of villous tissue 
Grade 6: Crypt layer infarction  
Grade 7: Transmucosal infarction  
Grade 8: Transmural infarction  
101,200 
Grade 0: Normal mucosa 
Grade 1: Sloughing of cells on villous tips was assigned a score of  
Grade 2: Mid-villous damage  
Grade 3: Villi were absent, but crypts were still readily detectable  
Grade 4: Complete absence of epithelial structures and transmural necrosis.  
89,105,141,201,2
02 
Grade 0: Normal 
Grade 1: Superficial epithelial injury  
Grade 2: Injury extending into lamina propria  
Grade 3: Injury extending into submucosa 
Grade 4: Injury extending into muscularis propria 
Grade 5: Full thickness injury  
95 
Grade 0: Normal villus  
Grade 1: Villi with tip distortion  
Grade 2: Goblet cells and Gugenheims’ spaces are missing  
Grade 3: Villi with patchy disruption of the epithelial cells 
Grade 4: Villi with exposed, but intact lamina propria with epithelial cell sloughing 
Grade 5: Lamina propria is exuding  
Grade 6: Villi that display hemorrhage or to villi that are denuded  
73,83-
86,96,103,104,15
5,198,199 
Grade 0: Normal histology 
Grade 1: Slight disruption of the surface epithelium 
Grade 2: Epithelial cell loss injury at villus tip 
Grade 3: Mucosal vasocongestion, hemorrhage, and focal necrosis with loss of less than -half of villi 
Grade 4: Damage extending to more than one-half of villi  
78,79 
Grade 0: Normal mucosal villous structure  
Grade 1: Presence of subepithelial space at villous tips  
Grade 2: Scattered epithelial denudation on villous tips  
Grade 3: Denuded tips with exposed lamina propria and villous blunting  
Grade 4: Epithelial shedding from both the apex and mid-region of the villi associated with shortened and 
widened villous structure  
Grade 5: Complete destruction of villi and disintegration of lamina propria with ulceration  
76 
Grade 0: no specific pathological changes are observed 
Grade 1: mild mucosal damage is observed, i.e., denudation of villi epithelium, otherwise normal structure.  
Grade 2: moderate damage occurs, i.e., loss of villus length and epithelial sloughing with evi- dence of 
congestion, hemorrhage, and inflammation in the mucosa, but no change in the submucosa or muscularis 
externa. 
Grade 3: extensive damage is observed, i.e., loss of a large number of villi, including denudation, sloughing, 
and the presence of granulomatous tissue; the damage is localized to submucosa and muscularis. 
Grade 4: there is severe damage and necrosis, i.e., inflammation and necrosis in areas throughout the 
thickness of the intestinal wall.  
98,203 
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Although it is clear that NOD2-mediated autophagy plays a role in our model 
of injury, the pathway connecting NOD2 to macroautophagy remains to be 
determined. In particular, it is important to decipher from which cellular compartment 
NOD2 mediates its protective effects, the mechanism by which NOD2 fosters the 
macroautophagy response during I/R injury, and how the relationship between the 
TLR/MyD88 and NOD2 pathways influences epithelial restitution. The first step 
toward answering these questions would be to perform injury on mice deficient in 
NOD2 in the IEC compartment and assess necrosis. We have generated these mice 
by crossing “floxed” Nod2 mice to mice expressing the Cre recombinase under the 
Villin promoter.  Similarly, Nod2 can be removed from myeloid cells by using a 
mouse expressing the Cre recomibinase under the Lysozyme 2 gene. It is likely that 
the protective effects of NOD2 originate from the IEC compartment as an increase in 
LC3+ puncta was observed in IECs in response to injury (Chapter 3, Figure 18). 
Hence, injury in IEC-specific knockout mice, but not myeloid-specific knockouts, may 
mimic the injury observed in the Nod2-/- mice. Narrowing down the cellular 
compartment is important to deciphering the signaling pathways downstream of 
NOD2, which likely engage macroautophagy. 
 By determining the NOD2 signaling pathway that contributes to 
macroautophagy, the connection between microbial signaling and the major 
molecular node that determines biogenesis, mTOR, would be elucidated. Due to 
protein degradation in ischemic tissue, novel cell-culture methods would be required 
to elucidate this pathway. For example, enteroids generated from the small bowel of 
WT and Nod2-/- mice could be exposed to hypoxic conditions and nutrient 
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deprivation and harvested for biochemical analysis of autophagic pathway markers 
including LC3-II and phosphorylated ULK1. 
Since the mTOR inhibitor rapamycin rescue Nod2-/- mice from I/R-induced 
injury, it would be important to molecularly define the role of mTOR in intestinal 
injury.  Mice defective for mTOR in either IEC or myeloid cells could be used to 
define the role of mTOR in MDP/Nod2-mediated protective effect. We have 
generated mTorIEC-/- mice and currently investigating the effect of this signaling 
pathway in I/R-induced injury. 
The signaling components from TLR/MyD88 and NOD2 are challenging to 
dissect because of the overlapping pathways through MAPK p38 and NF-κB. 
However, TLRs induce autophagy through a MyD88-independent pathway utilizing, 
instead, the adapter TRIM178. Using enteroids generated from the small bowel of 
MyD88-deficient mice, the impact of TLR-driven autophagy can be addressed in the 
context of hypoxia and nutrient deprivation. Here, NOD2 and TLR/TRIM signaling 
may synergize to augment the autophagy response. By measuring the autophagic 
response in MyD88-deficient enteroids stimulated with LPS and MDP, relative to the 
control, we can determine if these pathways jointly promote IEC survival in hypoxic 
conditions. Deciphering the relationship between NOD and TLR pathways will further 
our understanding of how MDP modulates the host response to injury.  
Although the majority of this work has focused on the signaling components 
downstream of NOD2, defining the role of the microbial groups that engage NOD2 is 
equally important.   Recent work by Nigro et al. demonstrated that NOD2 expression 
is higher in enteric stem cells than in Paneth cells, likely attributed to a crypt-specific 
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niche of microbes comprising Acinetobacter (genus) and Actinobacteria (class). 
These crypt-specific microbes induce NOD2 expression and signaling in enteric 
stem cells, which potentially fosters restitution of the intestinal epithelium after I/R-
induced injury.  In order to test how luminal microbes differ from crypt-specific 
microbes, epithelial restitution can be tested in GF WT mice gavaged with either 
crypt-specific microbes or lumen-specific microbes such as Bacteroides species205. 
Here, Acinetobacter and Actinobacteria would be expected to confer greater 
protection from ischemia-reperfusion injury than the lumen-specific microbes. The 
role of NOD2 signaling could also be tested in GF Nod2-/- mice gavaged with either 
crypt-specific or lumen-specific microbes. A better understanding of the types of 
microbes that engage NOD2 could potentially be used as therapeutic targets to 
reduce injury in susceptible patients, using pre- or probiotics.   
 
 Conclusions and Summary  4.3.
Despite the aforementioned remaining studies, this works demonstrates the 
microbial-mediated signaling through NOD2 and MYD88 heavily influences epithelial 
restitution. While MYD88 is deleterious, NOD2 protects the epithelium likely through 
the autophagy response. An outline of the proposed mechanisms is presented in 
(Figure 21). Activating NOD2, likely in the intestinal epithelial cell compartment, 
results in the induction of autophagy to enhance cell survival during the ischemia 
insult and support epithelial restitution thereafter. MyD88 signaling, on the other 
hand, causes further injury by inducing neutrophil recruitment to the site of injury. 
The evidence provided here warrants extending these observations through further 
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experimentation to elucidate the cellular compartment by which NOD2 confers 
protection, the role of microbial signaling in mTOR-regulated macroautophagy, and 
the role of crypt-specific microbes in the host injury response. Identifying how 
microbial signals impact epithelial restitution could provide novel pharmacological 
targets that could have profound benefits for patients suffering from this intestinal 
condition.  
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Figure 21. Microbial signaling in intestinal I/R-induced injury.  
NOD2 signaling is protective against ischemia/reperfusion-induced injury in the 
intestinal epithelium while MyD88 signaling is deleterious. NOD2 induces autophagy 
to enhance cell survival during the ischemia insult and supports epithelial restitution 
thereafter. MyD88 signaling induces neutrophil recruitment to the site of injury, 
through chemokine expression, exacerbating the injury. However, TLR-mediated 
(MyD88-indepdent) autophagy also likely protects the epithelium. 
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APPENDIX 
 
I would like to highlight my co-first author paper with Jason Goldsmith in the 
American Journal of Pathology. In addition, for my intellectual and technical 
contribution to our work, I was granted second-author in our paper to Science in 
2012. Here, I found that our E. coli strain NC101 contains the genotoxic island, pks.  
We hypothesize that intestinal inflammation fosters the bloom of this genotoxic 
E.coli, thereby enhancing tumorigenesis. 
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